Collective Molecular Activities of the Plant: Aster Bellidiastrum
Example Image
PLANiTS DNA barcode
Taxonomic Information
Plant ID: NPO8354
Plant Latin Name: Aster Bellidiastrum
Taxonomy Genus: Aster
Taxonomy Family: Asteraceae
Plant External Links:
NCBI TaxonomyDB:
191233
Plant-of-the-World-Online:
n.a.
Geographical Distribution
See the Plant Occurrence Worldwide with Latitude and Longitude Available
Compounds Summary
Overview of Ingredients
136 All known Ingredients in Total
Unique ingredients have been isolated from this plant.Plant-Ingredients Associations were manually curated from publications or collected from other databases.
112 Ingredients with Acceptable Bioavailablity
Unique ingredients exhibit acceptable human oral bioavailablity, according to the criteria of SwissADME [PMID: 28256516] and HobPre [PMID: 34991690]. The criteria details:SwissADME: six descriptors are used by SwissADME to evaluate the oral bioavailability of a natural product:
☑ LIPO(Lipophility): -0.7 < XLOGP3 < +5.0
☑ SIZE: 150g/mol < MW < 500g/mol
☑ POLAR(Polarity): 20Ų < TPSA < 130Ų
☑ INSOLU(Insolubility): -6 < Log S (ESOL) < 0
☑ INSATU(Insaturation): 0.25 < Fraction Csp3 < 1
☑ FLEX(Flexibility): 0 < Num. rotatable bonds < 9
If 6 descriptors of a natural plant satisfy the above rules, it will be labeled high HOB.
HobPre: A natural plant ingredient with HobPre score >0.5 is labeled high human oral availability (HOB)
57 Ingredients with experimental-derived Activity
Unique ingredients have activity data available.Ingredient Structrual Cards
Ingredient ID: NPC99968
Ingredient ID: NPC96572
Ingredient ID: NPC95973
Ingredient ID: NPC92032
Ingredient ID: NPC89890
Ingredient ID: NPC89474
Ingredient ID: NPC88756
Ingredient ID: NPC88439
Ingredient ID: NPC82501
Ingredient ID: NPC79419
Ingredient ID: NPC78225
Ingredient ID: NPC75372
Ingredient ID: NPC70460
Ingredient ID: NPC69769
Ingredient ID: NPC68093
Ingredient ID: NPC67650
Ingredient ID: NPC66475
Ingredient ID: NPC64407
Ingredient ID: NPC64061
Ingredient ID: NPC61010
Ingredient ID: NPC52611
Ingredient ID: NPC5052
Ingredient ID: NPC42054
Ingredient ID: NPC40864
Ingredient ID: NPC38739
Ingredient ID: NPC37870
Ingredient ID: NPC36605
Ingredient ID: NPC33051
Ingredient ID: NPC32243
Ingredient ID: NPC31913
Ingredient ID: NPC312823
Ingredient ID: NPC311750
Ingredient ID: NPC306847
Ingredient ID: NPC303742
Ingredient ID: NPC303187
Ingredient ID: NPC301710
Ingredient ID: NPC300727
Ingredient ID: NPC299732
Ingredient ID: NPC298409
Ingredient ID: NPC297323
Ingredient ID: NPC29480
Ingredient ID: NPC294558
Ingredient ID: NPC292859
Ingredient ID: NPC292725
Ingredient ID: NPC290928
Ingredient ID: NPC290467
Ingredient ID: NPC283262
Ingredient ID: NPC280128
Ingredient ID: NPC279242
Ingredient ID: NPC278760
Ingredient ID: NPC275780
Ingredient ID: NPC275090
Ingredient ID: NPC272552
Ingredient ID: NPC270578
Ingredient ID: NPC269443
Ingredient ID: NPC268946
Ingredient ID: NPC266499
Ingredient ID: NPC262307
Ingredient ID: NPC261800
Ingredient ID: NPC261729
Ingredient ID: NPC256364
Ingredient ID: NPC253543
Ingredient ID: NPC25152
Ingredient ID: NPC249394
Ingredient ID: NPC248638
Ingredient ID: NPC246010
Ingredient ID: NPC245511
Ingredient ID: NPC241904
Ingredient ID: NPC24161
Ingredient ID: NPC240537
Ingredient ID: NPC239518
Ingredient ID: NPC236521
Ingredient ID: NPC236202
Ingredient ID: NPC23317
Ingredient ID: NPC230775
Ingredient ID: NPC228785
Ingredient ID: NPC227337
Ingredient ID: NPC226108
Ingredient ID: NPC225613
Ingredient ID: NPC222341
Ingredient ID: NPC22133
Ingredient ID: NPC221202
Ingredient ID: NPC219876
Ingredient ID: NPC214702
Ingredient ID: NPC214360
Ingredient ID: NPC205772
Ingredient ID: NPC200704
Ingredient ID: NPC199789
Ingredient ID: NPC198043
Ingredient ID: NPC197206
Ingredient ID: NPC194856
Ingredient ID: NPC192228
Ingredient ID: NPC191146
Ingredient ID: NPC189473
Ingredient ID: NPC188433
Ingredient ID: NPC187097
Ingredient ID: NPC186397
Ingredient ID: NPC18457
Ingredient ID: NPC183307
Ingredient ID: NPC179315
Ingredient ID: NPC179227
Ingredient ID: NPC179065
Ingredient ID: NPC178964
Ingredient ID: NPC176388
Ingredient ID: NPC174097
Ingredient ID: NPC172259
Ingredient ID: NPC170245
Ingredient ID: NPC169479
Ingredient ID: NPC169171
Ingredient ID: NPC168977
Ingredient ID: NPC168247
Ingredient ID: NPC166054
Ingredient ID: NPC165977
Ingredient ID: NPC155259
Ingredient ID: NPC152951
Ingredient ID: NPC152872
Ingredient ID: NPC150977
Ingredient ID: NPC146134
Ingredient ID: NPC14353
Ingredient ID: NPC142339
Ingredient ID: NPC139501
Ingredient ID: NPC135801
Ingredient ID: NPC133970
Ingredient ID: NPC126029
Ingredient ID: NPC125252
Ingredient ID: NPC124319
Ingredient ID: NPC123437
Ingredient ID: NPC123416
Ingredient ID: NPC119224
Ingredient ID: NPC114056
Ingredient ID: NPC111951
Ingredient ID: NPC111758
Ingredient ID: NPC10926
Ingredient ID: NPC107672
Ingredient ID: NPC105598
Ingredient ID: NPC103318
Classification of Human Proteins Collectively Targeted by the Plant
*The classification criteria of Drug Transporter (DTP), CYP450 are referred to DrugMap. Other molecular targets in CMAUP are classified as therapeutic targets.
.
Detailed Information of Target Proteins
| Target Type | Protein Class | Gene ID | Protein Name | Uniprot ID | Target ChEMBL ID |
|---|---|---|---|---|---|
| Therapeutic Target | Enzyme | ALOX12 | Arachidonate 12-lipoxygenase | P18054 | CHEMBL3687 |
| Therapeutic Target | Enzyme | ALPL | Alkaline phosphatase, tissue-nonspecific isozyme | P05186 | CHEMBL5979 |
| Therapeutic Target | Oxidoreductase | PTGS1 | Cyclooxygenase-1 | P23219 | CHEMBL221 |
| Therapeutic Target | Phosphodiesterase 4 | PDE4D | Phosphodiesterase 4D | Q08499 | CHEMBL288 |
| Therapeutic Target | Structural protein | LMNA | Prelamin-A/C | P02545 | CHEMBL1293235 |
| Therapeutic Target | Transcription factor | NFKB1 | Nuclear factor NF-kappa-B p105 subunit | P19838 | CHEMBL3251 |
Clinical Trials Summary
Overview
Clinical trials associated with plant from natural product (NP) & plant level:
| Clinical trials type | Number of clinical trials | |
|---|---|---|
 NP level | 568 | |
Clinical trial details
| NCT ID | Title | Condition | Form in clinical use | Associated by plant or compound |
|---|---|---|---|---|
| NCT00856986 | The Effect of Insulin Detemir in Combination With Liraglutide and Metformin Compared to Liraglutide and Metformin in Subjects With Type 2 Diabetes | type 2 diabetes mellitus | Metformin (NPC230775) | NP level |
| NCT00798161 | Safety and Efficacy of Linagliptin (BI 1356) Plus Metformin in Type 2 Diabetes, Factorial Design | type 2 diabetes mellitus | Metformin (NPC230775) | NP level |
| NCT04530058 | The Effects of Metformin on Morbidity and Mortality in Elderly Patients | burn | Metformin (NPC230775) | NP level |
| NCT04113889 | Effects of Triple Drug Cocktail Therapy on Metabolic, Endocrine Alterations and Perceived Stress in Patients With Poly Cystic Ovary Syndrome | polycystic ovary syndrome | Metformin (NPC230775) | NP level |
| NCT01677897 | Impact of the Addition of Metformin to Abiraterone in Metastatic Prostate Cancer Patients | metastatic prostate cancer | Metformin (NPC230775) | NP level |
| NCT02945813 | SAKK 08/15 - PROMET - Salvage Radiotherapy +/- Metformin for Patients With Prostate Cancer After Prostatectomy | prostate cancer | Metformin (NPC230775) | NP level |
| NCT02815397 | DA-EPOCH-Rituximab/Metformin (RM) for Double Hit Lymphoma | diffuse large B-cell lymphoma | Metformin (NPC230775) | NP level |
| NCT00770445 | Efficacy of Pioglitazone and Metformin on Cardiovascular Risk in Subjects With Insulin-Treated Type 2 Diabetes Mellitus. | diabetes mellitus | Metformin (NPC230775) | NP level |
| NCT01725126 | To Investigate the Safety, Tolerability and Pharmacodynamics of GSK2890457 in Healthy Volunteers and Subjects With Type 2 Diabetes | obesity | Metformin (NPC230775) | NP level |
| NCT00789191 | Effect of Detemir and Sitagliptin on Blood Glucose Control in Type 2 Diabetes | type 2 diabetes mellitus | Metformin (NPC230775) | NP level |
| NCT01632020 | Effect of Metformin on Biomarkers of Colorectal Tumor Cell Growth | colorectal neoplasm | Metformin (NPC230775) | NP level |
| NCT02088034 | Intervention to Promote Weight Loss in Latinas At-risk for Diabetes | diabetes mellitus | Metformin (NPC230775) | NP level |
| NCT01622257 | Cavitation Ultrasound in Treatment of Patients With PCOS | polycystic ovary syndrome | Metformin (NPC230775) | NP level |
| NCT00885352 | Sitagliptin (MK-0431) vs. Placebo in Patients With Inadequate Glycemic Control on Metformin With Pioglitazone (MK-0431-128) | type 2 diabetes mellitus | Metformin (NPC230775) | NP level |
| NCT00762957 | Safety and Efficacy of TAK-559 in Combination With Metformin in Patients With Type 2 Diabetes Mellitus. | diabetes mellitus | Metformin (NPC230775) | NP level |
| NCT01034111 | A Local Experiential Study With Sitagliptin (an Antihyperglycemic Drug) in 30 Patients With Type 2 Diabetes Mellitus (0431-178) | type 2 diabetes mellitus | Metformin (NPC230775) | NP level |
| NCT04530747 | Metabolic Effects of Metformin Therapy in Obstructive Sleep Apnea | obstructive sleep apnea | Metformin (NPC230775) | NP level |
| NCT01365091 | Bioequivalence Study of Fixed-dose Combinations and Coadministered Individual Tablets of Saxagliptin/Metformin-Brazil | type 2 diabetes mellitus | Metformin (NPC230775) | NP level |
| NCT00111631 | A Study of DPP-IV Inhibitor in Patients With Type 2 Diabetes | type 2 diabetes mellitus | Metformin (NPC230775) | NP level |
| NCT00108615 | Effects of Insulin Sensitizers in Subjects With Impaired Glucose Tolerance | diabetes mellitus | Metformin (NPC230775) | NP level |
| NCT01779375 | RISE Pediatric Medication Study | prediabetes syndrome | Metformin (NPC230775) | NP level |
| NCT00362323 | Fenofibrate and Metformin Fixed Combination vs Metformin - FAME METFO | metabolic disease | Metformin (NPC230775) | NP level |
| NCT00627445 | Effect of Biphasic Insulin Aspart 50 on Blood Glucose Control in Subjects With Type 2 Diabetes | type 2 diabetes mellitus | Metformin (NPC230775) | NP level |
| NCT00851903 | Evaluation of Insulin Glargine in Combination With Sitagliptin in Type 2 Diabetes Patients: EASIE Extension Trial | type 2 diabetes mellitus | Metformin (NPC230775) | NP level |
| NCT04973891 | CANA/Met in Non-diabetic Women With PCOS | polycystic ovary syndrome | Metformin (NPC230775) | NP level |
| NCT04511416 | Preventing Cognitive Decline With Metformin | Mental deterioration | Metformin (NPC230775) | NP level |
| NCT00714233 | Treatment of Adolescent Polycystic Ovary Syndrome (PCOS) | polycystic ovary syndrome | Metformin (NPC230775) | NP level |
| NCT02506790 | Neoadjuvant Toremifene With Melatonin or Metformin in Locally Advanced Breast Cancer | breast cancer | Metformin (NPC230775) | NP level |
| NCT01089179 | Bioequivalence Study of Metformin Hydrochloride Extended Release 500 mg Tablet Versus Glucophage XR® 500 mg Tablet in Healthy Volunteers Under Fed Conditions | type 2 diabetes mellitus | Metformin (NPC230775) | NP level |
| NCT03200015 | Rituximab, Cyclophosphamide, Vincristine and Prednisone (R-CHOP) Plus Metformin in Diffuse Large-B-cell Lymphoma | diffuse large B-cell lymphoma | Metformin (NPC230775) | NP level |
| NCT00350779 | Sitagliptin Metformin/PPARg Agonist Combination Therapy Add-on (0431-052) | type 2 diabetes mellitus | Metformin (NPC230775) | NP level |
| NCT02956044 | Interaction of Bexagliflozin With Metformin, Glimepiride and Sitagliptin | diabetes mellitus | Metformin (NPC230775) | NP level |
| NCT00727857 | Efficacy and Safety of Pioglitazone and Metformin Combination Therapy in Treating Type 2 Diabetes Mellitus. | diabetes mellitus | Metformin (NPC230775) | NP level |
| NCT02931253 | Metformin as an Upstream Therapy in Atrial Fibrillation | atrial fibrillation | Metformin (NPC230775) | NP level |
| NCT01336322 | Metformin and Sitagliptin in Women With Previous Gestational Diabetes | prediabetes syndrome | Metformin (NPC230775) | NP level |
| NCT00063232 | Treating Nonalcoholic Steatohepatitis (NASH) With Metformin | Hepatitis | Metformin (NPC230775) | NP level |
| NCT05215990 | Efficacy of Metformin for Sputum Conversion in Patients With Active Pulmonary Tuberculosis | tuberculosis | Metformin (NPC230775) | NP level |
| NCT01528046 | Metformin in Children With Relapsed or Refractory Solid Tumors | brain neoplasm | Metformin (NPC230775) | NP level |
| NCT03192293 | Metformin and Simvastatin in Addition to Fulvestrant | breast cancer | Metformin (NPC230775) | NP level |
| NCT01880866 | (-)-Epicatechin and Pulmonary Arterial Hypertension | pulmonary arterial hypertension | (-)-Epicatechin (NPC126029) | NP level |
| NCT05468554 | Evaluation of Metformin Effect on the Fertility of Women Treated With 131I for Thyroid Cancer | thyroid cancer | Metformin (NPC230775) | NP level |
| NCT01710527 | BE Study of Metformin GSK 500mg | diabetic foot | Metformin (NPC230775) | NP level |
| NCT00960661 | A Trial Comparing Two Therapies: Basal Insulin/Glargine, Exenatide and Metformin Therapy (BET) or Basal Insulin/Glargine, Bolus Insulin Lispro and Metformin Therapy (BBT) in Subjects With Type 2 Diabetes | type 2 diabetes mellitus | Metformin (NPC230775) | NP level |
| NCT02506777 | Neoadjuvant FDC With Melatonin or Metformin for Locally Advanced Breast Cancer. | breast cancer | Metformin (NPC230775) | NP level |
| NCT04839237 | The Effect and the Pharmacogenomics Study of Liraglutide in Obese Patients | obesity | Metformin (NPC230775) | NP level |
| NCT04500756 | Limiting AAA With Metformin (LIMIT) Trial | Abdominal Aortic Aneurysm | Metformin (NPC230775) | NP level |
| NCT02981329 | Fetal Hemoglobin Induction Treatment Metformin | sickle cell anemia | Metformin (NPC230775) | NP level |
| NCT00699036 | Rosiglitazone Versus Rosiglitazone and Metformin Versus Rosiglitazone and Avandia in the Treatment of Nonalcoholic Steatohepatitis (NASH) | non-alcoholic steatohepatitis | Metformin (NPC230775) | NP level |
| NCT03863405 | Metformin Use in Rheumatoid Arthritis | rheumatoid arthritis | Metformin (NPC230775) | NP level |
| NCT01766778 | Early add-on Vildagliptin in Patients With Type 2 Diabetes Inadequately Controlled by Metformin | diabetes mellitus | Metformin (NPC230775) | NP level |
| NCT02028221 | Phase II Study of Metformin for Reduction of Obesity-Associated Breast Cancer Risk | breast cancer | Metformin (NPC230775) | NP level |
| NCT03618654 | Durvalumab With or Without Metformin in Treating Participants With Head and Neck Squamous Cell Carcinoma | oral squamous cell carcinoma;oropharynx squamous cell carcinoma | Metformin (NPC230775) | NP level |
| NCT04264897 | Antecedent Metabolic Health and Metformin Aging Study | aging;insulin resistance | Metformin (NPC230775) | NP level |
| NCT00871936 | A Comparison of SLx-4090 in Combination With Metformin Versus Metformin Therapy Alone in Patients With Type 2 Diabetes | type 2 diabetes mellitus | Metformin (NPC230775) | NP level |
| NCT01996696 | Prevention of Metabolic Syndrome and Increased Weight Using Metformin Concurrent to Androgen Deprivation Therapy and Radiotherapy for Locally Advanced Adenocarcinoma of the Prostate | prostate adenocarcinoma | Metformin (NPC230775) | NP level |
| NCT01750567 | A Pilot Study of Metformin Therapy in Patients With Relapsed Chronic Lymphocytic Leukemia (CLL) and Untreated CLL | chronic lymphocytic leukemia | Metformin (NPC230775) | NP level |
| NCT02684578 | Metformin for the Minimization of Geographic Atrophy Progression in Patients With AMD | atrophic macular degeneration | Metformin (NPC230775) | NP level |
| NCT02457286 | Improving Insulin Resistance To Treat Non-Alcoholic Fatty Liver Disease: A Pilot Study | non-alcoholic fatty liver disease | Metformin (NPC230775) | NP level |
| NCT05440591 | Effects of Dapagliflozin and Metformin on Vascular Function in Newly-Diagnosed Treatment-Naive Type 2 Diabetes | diabetes mellitus | Metformin (NPC230775) | NP level |
| NCT02325401 | Dose-finding Study of Metformin With Chemoradiation in Locally Advanced Head and Neck Squamous Cell Carcinoma | head and neck malignant neoplasia | Metformin (NPC230775) | NP level |
| NCT01106677 | The CANTATA-D Trial (CANagliflozin Treatment and Trial Analysis - DPP-4 Inhibitor Comparator Trial) | type 2 diabetes mellitus | Metformin (NPC230775) | NP level |
| NCT01289119 | Efficacy and Safety of Alogliptin in Participants With Type 2 Diabetes | type 2 diabetes mellitus | Metformin (NPC230775) | NP level |
| NCT01779362 | RISE Adult Medication Study | prediabetes syndrome | Metformin (NPC230775) | NP level |
| NCT00707031 | GLP-1 Receptor Agonist Lixisenatide Versus Exenatide in Patients With Type 2 Diabetes for Glycemic Control and Safety Evaluation, on Top of Metformin | type 2 diabetes mellitus | Metformin (NPC230775) | NP level |
| NCT04098666 | Metformin in Alzheimer's Dementia Prevention | Cognitive impairment | Metformin (NPC230775) | NP level |
| NCT04817787 | Exercise Dose and Metformin for Vascular Health in Adults With Metabolic Syndrome | metabolic syndrome | Metformin (NPC230775) | NP level |
| NCT04559308 | The Effect of Metformin on Breast Cancer Patients | breast cancer | Metformin (NPC230775) | NP level |
| NCT03229057 | Comparing the Effects of Oral Contraceptive Pills Versus Metformin | polycystic ovary syndrome | Metformin (NPC230775) | NP level |
| NCT00728351 | Efficacy and Safety of Fixed Combination Therapy of Vildagliptin and Metformin (25/1000 mg Bid) in Patients With Type 2 Diabetes Inadequately Controlled With Prior Metformin Monotherapy (HbA1c 7.0-9.5%) | type 2 diabetes mellitus | Metformin (NPC230775) | NP level |
| NCT00684528 | A Double-Blind, Randomized, Active-Comparator (Metformin) Controlled, Clinical Trial to Study the Efficacy and Safety of the Strategy to Start Patients With Type 2 Diabetes Mellitus on Janumet™ Compared to Metformin | diabetes mellitus | Metformin (NPC230775) | NP level |
| NCT00969566 | Predictive Parameters for Efficacy of Sitagliptin and Metformin Combination | diabetes mellitus | Metformin (NPC230775) | NP level |
| NCT00543361 | Study MK0767 and Metformin in Type 2 Diabetic Patients (0767-020) | type 2 diabetes mellitus | Metformin (NPC230775) | NP level |
| NCT00399711 | Effect of Repaglinide and Metformin Combination Tablet or Rosiglitazone and Metformin in Fixed Dose Combination on Blood Glucose Control in Patients With Type 2 Diabetes | type 2 diabetes mellitus | Metformin (NPC230775) | NP level |
| NCT05093959 | Metformin for Older Patients With Heart Failure With Preserved Ejection Fraction Pilot Study | heart failure | Metformin (NPC230775) | NP level |
| NCT00915772 | Treatment of Type 2 Diabetes With Linagliptin 2.5 mg Bid + Metformin 500 or 1000 mg Bid and Metformin 1000 mg Bid | type 2 diabetes mellitus | Metformin (NPC230775) | NP level |
| NCT00361868 | Fenofibrate and Metformin Fixed Combination vs Rosiglitazone - FAME ROSI | Disorder of lipid metabolism | Metformin (NPC230775) | NP level |
| NCT01329016 | Glyburide and Metformin for Gestational Diabetes Mellitus (GDM) | gestational diabetes | Metformin (NPC230775) | NP level |
| NCT03617458 | Interventions Against Insulin Resistance in Pulmonary Arterial Hypertension | pulmonary arterial hypertension | Metformin (NPC230775) | NP level |
| NCT01089166 | Study to Compare the Bioavailability of Extended Release Metformin HCl Tablet Versus Glucophage XR® Tablets in Healthy Human Volunteers Under Fasting Condition | type 2 diabetes mellitus | Metformin (NPC230775) | NP level |
| NCT02283554 | Platelet Rich Fibrin With 1% Metformin Gel for Treatment of Intrabony Defects | periodontitis | Metformin (NPC230775) | NP level |
| NCT02275845 | Medico-GDM Trial - Metformine to Prevent Gestational Diabetes Mellitus | gestational diabetes | Metformin (NPC230775) | NP level |
| NCT02278965 | Metformin and Omega-3 Fatty Acids in Woman With a History of Early Stage Breast Cancer | breast carcinoma in situ | Metformin (NPC230775) | NP level |
| NCT02696941 | SGLT2 Inhibitors and Metformin on Metabolism and Non-Alcoholic SteatoHepatitis | non-alcoholic fatty liver disease | Metformin (NPC230775) | NP level |
| NCT00481663 | A Study of Different Doses of Sitagliptin (MK-0431) in Participants With Type 2 Diabetes Mellitus (MK-0431-014) | type 2 diabetes mellitus | Metformin (NPC230775) | NP level |
| NCT04972396 | ALT-801 DDI Study in Healthy Volunteers | non-alcoholic steatohepatitis | Metformin (NPC230775) | NP level |
| NCT02022007 | Saxagliptin + Metformin Compared to Saxagliptin or Metformin Monotherapy in PCOS Women With Impaired Glucose Homeostasis | polycystic ovary syndrome | Metformin (NPC230775) | NP level |
| NCT01071850 | A Study to Evaluate the Effect of ASP1941 in Adult Patients With Type 2 Diabetes Mellitus | type 2 diabetes mellitus | Metformin (NPC230775) | NP level |
| NCT02780024 | Metformin, Neo-adjuvant Temozolomide and Hypo- Accelerated Radiotherapy Followed by Adjuvant TMZ in Patients With GBM | glioblastoma multiforme | Metformin (NPC230775) | NP level |
| NCT02394652 | The Potential for Metformin to Improve Tumor Oxygenation in Locally Advanced Cervix Cancer: A Phase II Randomized Trial | cervical adenocarcinoma;squamous cell carcinoma | Metformin (NPC230775) | NP level |
| NCT02045290 | Insulin Clamp Ancillary Study for Assessment of Insulin Resistance | type 1 diabetes mellitus | Metformin (NPC230775) | NP level |
| NCT01357876 | Effect of Metformin on Gut Peptides , Bile Acids and Lipid Profiles in Type 2 Diabetics | type 2 diabetes mellitus | Metformin (NPC230775) | NP level |
| NCT01167738 | Combination Chemotherapy With or Without Metformin Hydrochloride in Treating Patients With Metastatic Pancreatic Cancer | pancreatic carcinoma | Metformin (NPC230775) | NP level |
| NCT02285855 | Metformin in Non Small Cell Lung Cancer (NSCLC) | lung cancer | Metformin (NPC230775) | NP level |
| NCT00673465 | Effect of SCH 497079 on Metabolic Parameters and Influence of Race/Ethnic Origin on Therapeutic Response (Study P05338)(COMPLETED) | type 2 diabetes mellitus | Metformin (NPC230775) | NP level |
| NCT02644954 | Assessing the Efficacy and Safety of Metformin in Treatment of Moderate Psoriasis | psoriasis | Metformin (NPC230775) | NP level |
| NCT02279758 | A Pilot Study of Metformin Treatment in Patients With Well-differentiated Neuroendocrine Tumors | neuroendocrine neoplasm | Metformin (NPC230775) | NP level |
| NCT00975286 | 24-week Treatment With Lixisenatide in Type 2 Diabetes Insufficiently Controlled With Metformin and Insulin Glargine | type 2 diabetes mellitus | Metformin (NPC230775) | NP level |
| NCT00676338 | Safety and Efficacy of Exenatide Once Weekly Injection Versus Metformin, Dipeptidyl Peptidase-4 Inhibitor, or Thiazolidinedione as Monotherapy in Drug-Naive Patients With Type 2 Diabetes (DURATION-4) | type 2 diabetes mellitus | Metformin (NPC230775) | NP level |
| NCT00900146 | Dose Finding, Safety and Efficacy of Monthly Subcutaneous Canakinumab Administration in Metformin Monotherapy Treated Type 2 Diabetic Patients | type 2 diabetes mellitus | Metformin (NPC230775) | NP level |
| NCT04604678 | Pilot Study Into the Use of Metformin and LDN for Patients With COVID-19 | COVID-19 | Metformin (NPC230775) | NP level |
| NCT02042664 | Effect of GLP-1 Receptor (GLP-1R) Agonists on Cardiac Function and on Epicardial Adipose Tissue (EAT) Volume and on Myocardial TG Content in Obese Diabetics | diabetes mellitus | Metformin (NPC230775) | NP level |
| NCT00097500 | Effects of Exenatide and Insulin Glargine in Subjects With Type 2 Diabetes | type 2 diabetes mellitus | Metformin (NPC230775) | NP level |
| NCT04742751 | An Open-Label Pilot Intervention Trial to Prevent Diabetes in Prediabetic Adult Survivors of Childhood Cancer | prediabetes syndrome | Metformin (NPC230775) | NP level |
| NCT00103857 | MK0431 (Sitagliptin) and Metformin Co-Administration Factorial Study in Patients With Type 2 Diabetes Mellitus (0431-036) | type 2 diabetes mellitus | Metformin (NPC230775) | NP level |
| NCT02516085 | Improved Muscle Function in Duchenne Muscular Dystrophy Through L-Arginine and Metformin | Duchenne muscular dystrophy | Metformin (NPC230775) | NP level |
| NCT02083692 | Pilot Study of Metformin in Head and Neck Squamous Cell Cancer and Its Effects on Stromal-epithelial Metabolic Uncoupling | squamous cell carcinoma | Metformin (NPC230775) | NP level |
| NCT03137186 | Repurposing Metformin as Anticancer Drug: in Advanced Prostate Cancer | prostate cancer | Metformin (NPC230775) | NP level |
| NCT03681197 | Metformin Use and Clinical Pregnancy Rate in Women With Unexplained Infertility | infertility | Metformin (NPC230775) | NP level |
| NCT01725490 | The Chemopreventive Effect of Metformin in Patients With Familial Adenomatous Polyposis: Double Blinded Randomized Controlled Study | Familial adenomatous polyposis | Metformin (NPC230775) | NP level |
| NCT00661362 | Evaluate Efficacy and Safety of Saxagliptin in Combination With Metformin in Adult Patients With Type 2 Diabetes | type 2 diabetes mellitus | Metformin (NPC230775) | NP level |
| NCT00110851 | Safety and Efficacy Study of PN2034 in Type 2 Diabetes Patients on Concomitant Rosiglitazone and Metformin (or Avandamet) | type 2 diabetes mellitus | Metformin (NPC230775) | NP level |
| NCT00102466 | Vildagliptin Compared to Gliclazide in Combination With Metformin in Patients With Type 2 Diabetes | type 2 diabetes mellitus | Metformin (NPC230775) | NP level |
| NCT01210911 | Metformin Combined With Chemotherapy for Pancreatic Cancer | pancreatic carcinoma | Metformin (NPC230775) | NP level |
| NCT00331851 | Effect of Liraglutide on Blood Glucose Control in Subjects With Type 2 Diabetes | type 2 diabetes mellitus | Metformin (NPC230775) | NP level |
| NCT00327015 | A Phase 3 Study of BMS-477118 in Combination With Metformin in Subjects With Type 2 Diabetes Who Are Not Controlled With Diet and Exercise | diabetes mellitus | Metformin (NPC230775) | NP level |
| NCT01087983 | Lapatinib With Sirolimus or Metformin | cancer | Metformin (NPC230775) | NP level |
| NCT02312661 | Study of Metformin With Carboplatin/Paclitaxel Chemotherapy in Patients With Advanced Ovarian Cancer | ovarian cancer | Metformin (NPC230775) | NP level |
| NCT01915550 | Metformin as Adjuvant to Insulin Therapy in Insulin-resistant Diabetes Mellitus With Pregnancy | diabetes mellitus | Metformin (NPC230775) | NP level |
| NCT00375388 | The HOME Trial: Hyperinsulinaemia: the Outcome of Its Metabolic Effects, a Randomized Controlled Trial | type 2 diabetes mellitus | Metformin (NPC230775) | NP level |
| NCT01797523 | A Phase II, Single-Arm Study of RAD001 (Everolimus), Letrozole, and Metformin in Patients With Advanced or Recurrent Endometrial Carcinoma | endometrial cancer | Metformin (NPC230775) | NP level |
| NCT01296412 | Comparison of Two Treatment Regimens (Sitagliptin Versus Liraglutide) on Participants Who Failed to Achieve Good Glucose Control on Metformin Alone (MK-0431-403) | type 2 diabetes mellitus | Metformin (NPC230775) | NP level |
| NCT02063802 | Metformin vs Conjugated Linoleic Acid and an Intervention Program With Healthy Habits in Obese Children | obesity | Metformin (NPC230775) | NP level |
| NCT01305551 | BE Study of the Fixed Dose Combination of 5 mg Saxagliptin and 500 mg Metformin HCl XR Tablet Relative to a 5 mg Saxagliptin (Onglyza™) Tablet and a 500 mg Metformin HCl XR (Glifage® XR Marketed in Brazil by Merck S.A.) Tablet Co-Administered to Healthy Subjects in the Fasted and Fed States | type 2 diabetes mellitus | Metformin (NPC230775) | NP level |
| NCT01106690 | The CANTATA-MP Trial (CANagliflozin Treatment and Trial Analysis - Metformin and Pioglitazone) | type 2 diabetes mellitus | Metformin (NPC230775) | NP level |
| NCT02990728 | Mirena® ± Metformin as Fertility-preserving Treatment for Young Asian Women With Early Endometrial Cancer | endometrial cancer | Metformin (NPC230775) | NP level |
| NCT01211197 | Bioavailability of a Fixed Dose Combination Tablet With Empagliflozin (BI 10773) and Metformin Compared With the Monocomponents and Effect of Food on Bioavailability | type 2 diabetes mellitus | Metformin (NPC230775) | NP level |
| NCT02026869 | Vaginal Administration of Metformin in PCOS Patients. | polycystic ovary syndrome | Metformin (NPC230775) | NP level |
| NCT05243654 | Efficacy and Tolerability of Adjunct Metformin for Multibacillary Leprosy | leprosy | Metformin (NPC230775) | NP level |
| NCT01089192 | Bioequivalence Study of Metformin Hydrochloride Extended Release 750 mg Tablets Versus Glucophage XR® 750 mg Tablet in Healthy Volunteers Under Fasting Conditions. | type 2 diabetes mellitus | Metformin (NPC230775) | NP level |
| NCT02844803 | Study of Metformin and S. Baicalensis Combination Therapy in Type 2 Diabetes Mellitus Patients | diabetes mellitus | Metformin (NPC230775) | NP level |
| NCT02274090 | 1% Metformin in Moderate and Severe Periodontitis | periodontitis | Metformin (NPC230775) | NP level |
| NCT00614055 | Comparison of Two NN5401 Formulations Versus Insulin Glargine, All in Combination With Metformin in Subjects With Type 2 Diabetes | type 2 diabetes mellitus | Metformin (NPC230775) | NP level |
| NCT03311308 | A Trial of Pembrolizumab and Metformin Versus Pembrolizumab Alone in Advanced Melanoma | melanoma | Metformin (NPC230775) | NP level |
| NCT04926155 | The Effect of Metformin in Patients With Metastatic Castration-resistant Prostate Cancer | metastatic prostate cancer | Metformin (NPC230775) | NP level |
| NCT00279045 | Diabetes Study With Rosiglitazone Monotherapy Versus Metformin Or Glyburide/Glibenclamide | type 2 diabetes mellitus | Metformin (NPC230775) | NP level |
| NCT01046422 | Safety Study of BMS-770767 in Subjects With Type 2 Diabetes | diabetes mellitus | Metformin (NPC230775) | NP level |
| NCT02498522 | Effect of Metformin on Early Pregnancy Loss in Pregnant Women With Polycystic Ovarian Syndrome | polycystic ovary syndrome | Metformin (NPC230775) | NP level |
| NCT02640534 | Investigation of Metformin in Patients With Castration Resistant Prostate Cancer in Combination With Enzalutamide vs. Enzalutamide Alone | prostate carcinoma | Metformin (NPC230775) | NP level |
| NCT01215331 | Gestational Diabetes: Insulin or Oral Hypoglycemic Agents? | gestational diabetes | Metformin (NPC230775) | NP level |
| NCT03981861 | Metabolic and Neuro-Endocrine Effect of Treating PCOS in Adolescents | polycystic ovary syndrome | Metformin (NPC230775) | NP level |
| NCT00961480 | A Study to Demonstrate the Bioequivalence of Sitagliptin/Metformin Combination Tablets and Co-administration of Sitagliptin and Metformin as Individual Tablets (0431A-095) | type 2 diabetes mellitus | Metformin (NPC230775) | NP level |
| NCT00396357 | Efficacy/Safety of Vildagliptin and Metformin Combination Therapy in Patients With Type 2 Diabetes Not Well Controlled With Metformin Alone | type 2 diabetes mellitus | Metformin (NPC230775) | NP level |
| NCT03841591 | Maternal Weight Gain in Gestational Diabetes Controlled by Metformin Versus Insulin | gestational diabetes | Metformin (NPC230775) | NP level |
| NCT00468039 | A Sub-study to LMF237A2302 to Assess the Effect of 24 Weeks Treatment With Initial Combination of Vildagliptin Plus Metformin | type 2 diabetes mellitus | Metformin (NPC230775) | NP level |
| NCT01037660 | Effects of Lipemia and Metformin on Endothelial Function | cardiovascular disease | Metformin (NPC230775) | NP level |
| NCT01084486 | Effect of Treatment With Insulin Sensitizer on Arterial Properties, Metabolic Parameters and Liver Function in Patients With Nonalcoholic Fatty Liver Disease | non-alcoholic fatty liver disease | Metformin (NPC230775) | NP level |
| NCT00541775 | Safety/Efficacy of Sitagliptin in Patient w/ Type 2 Diabetes (0431-801) | type 2 diabetes mellitus | Metformin (NPC230775) | NP level |
| NCT04414540 | Combining Pembrolizumab and Metformin in Metastatic Head and Neck Cancer Patients | head and neck squamous cell carcinoma | Metformin (NPC230775) | NP level |
| NCT04865835 | A Clinical Trial Study to Determine the Effect of an Investigational Drug (SEP-363856) Has on the Way That the Drug Metformin Travels Through the Body in People With Schizophrenia. | schizophrenia | Metformin (NPC230775) | NP level |
| NCT03848533 | Effect of Melatonin and Metformin on Glycemic Control Genotoxicity and Cytotoxicity Markers in Patients With Prediabetes | prediabetes syndrome | Metformin (NPC230775) | NP level |
| NCT02946996 | Study of Pharmacologic Manipulation of AGE (Advanced Glycation Endproducts) Levels in Prostate Cancer Patients Receiving Androgen Deprivation Therapy | prostate cancer | Metformin (NPC230775) | NP level |
| NCT04300790 | Study to Evaluate the Effect of Metformin in the Prevention of HG in HR[+]/HER2[-] PIK3CA-mut Advanced BC Patients | breast cancer | Metformin (NPC230775) | NP level |
| NCT04925063 | The Effect of Metformin in Patients With Newly Diagnosed mHSPC | metastatic prostate cancer | Metformin (NPC230775) | NP level |
| NCT03833466 | Metformin in Combined With Cisplatin Plus Paclitaxel With Advanced Esophageal Squamous Cell Carcinoma (ECMTPneo) | esophageal squamous cell carcinoma | Metformin (NPC230775) | NP level |
| NCT00121641 | Saxagliptin Treatment in Subjects With Type 2 Diabetes Who Are Not Controlled With Diet and Exercise | type 2 diabetes mellitus | Metformin (NPC230775) | NP level |
| NCT00712673 | GLP-1 Receptor Agonist Lixisenatide (Morning or Evening) in Patients With Type 2 Diabetes for Glycemic Control and Safety Evaluation, on Top of Metformin | type 2 diabetes mellitus | Metformin (NPC230775) | NP level |
| NCT01332071 | Avandamet Bioequivalence Study Brazil - Fed Administration | type 2 diabetes mellitus | Metformin (NPC230775) | NP level |
| NCT00620191 | Metformin in Amnestic Mild Cognitive Impairment | Cognitive impairment | Metformin (NPC230775) | NP level |
| NCT02967276 | Clinical Activity of Metformin With High-dose of Dexamethasone in Relapse Multiple Myeloma | multiple myeloma | Metformin (NPC230775) | NP level |
| NCT00376038 | Drug Interactions From Simultaneous Administration Of Metformin And GSK189075 To Subjects With Type 2 Diabetes | type 2 diabetes mellitus | Metformin (NPC230775) | NP level |
| NCT01733836 | Prostate Cancer Active Surveillance Metformin Trial | prostate cancer | Metformin (NPC230775) | NP level |
| NCT04050098 | Bioequivalence Study for Gemigliptin/Metformin 50/1000 mg and Coadministration of Gemigliptin 50 mg and Metformin 1000 mg. | diabetes mellitus | Metformin (NPC230775) | NP level |
| NCT00772174 | Efficacy and Safety Study of Pioglitazone Combined With Metformin on Metabolic Syndrome in Subjects With Type 2 Diabetes | diabetes mellitus | Metformin (NPC230775) | NP level |
| NCT03477162 | Metformin Pharmacology in Human Cancers: A Proof of Principle Study | neoplasm of thorax | Metformin (NPC230775) | NP level |
| NCT04177303 | Incretin Hormones in Type 1 Diabetes Mellitus | type 1 diabetes mellitus | Metformin (NPC230775) | NP level |
| NCT03238495 | Randomized Trial of Neo-adjuvant Chemotherapy With or Without Metformin for HER2 Positive Operable Breast Cancer | breast cancer | Metformin (NPC230775) | NP level |
| NCT00374907 | A Study Assessing Saxagliptin Treatment in Subjects With Type 2 Diabetes Who Are Not Controlled With Diet and Exercise | type 2 diabetes mellitus | Metformin (NPC230775) | NP level |
| NCT03030300 | Remission Rate of Newly Diagnosed Type 2 Diabetes Outpatients Treated With Short-term Intensive Insulin Therapy | diabetes mellitus | Metformin (NPC230775) | NP level |
| NCT00571519 | Randomized, Double-blind, Active-controlled, Study of Rivoglitazone in Type 2 Diabetes Mellitus | type 2 diabetes mellitus | Metformin (NPC230775) | NP level |
| NCT00899470 | Bioequivalence Study of Saxagliptin and Glucophage Combination Formulations in Healthy Subjects (A) | type 2 diabetes mellitus | Metformin (NPC230775) | NP level |
| NCT01881828 | Metformin Therapy for Overweight Adolescents With Type 1 Diabetes | type 1 diabetes mellitus | Metformin (NPC230775) | NP level |
| NCT00286442 | Efficacy and Safety of Alogliptin Combined With Metformin in Participants With Type 2 Diabetes Mellitus | diabetes mellitus | Metformin (NPC230775) | NP level |
| NCT05183204 | Paxalisib With a High Fat, Low Carb Diet and Metformin for Glioblastoma | glioblastoma multiforme | Metformin (NPC230775) | NP level |
| NCT00960076 | An 18 Week Efficacy and Safety Study of Saxagliptin and Metformin XR Combination in Subjects With Type 2 Diabetes | type 2 diabetes mellitus | Metformin (NPC230775) | NP level |
| NCT01215032 | Metformin in Castration-Resistant Prostate Cancer | prostate cancer | Metformin (NPC230775) | NP level |
| NCT03117517 | Treatment With Metformin and Combination of Metformin and Pioglitazone in Polycystic Ovarian Syndrome | polycystic ovary syndrome | Metformin (NPC230775) | NP level |
| NCT02460354 | Metformin and Congenital Nephrogenic Diabetes Insipidus | diabetes insipidus | Metformin (NPC230775) | NP level |
| NCT00318461 | To Compare the Effect of Liraglutide When Given Together With Metformin With the Effect of Metformin Given Alone and With the Effect of Glimepiride and Metformin Given Together | type 2 diabetes mellitus | Metformin (NPC230775) | NP level |
| NCT04416269 | Oral Anti Diabetic Agents in the Hospital | diabetes mellitus | Metformin (NPC230775) | NP level |
| NCT04510194 | COVID-OUT: Early Outpatient Treatment for SARS-CoV-2 Infection (COVID-19) | COVID-19;severe acute respiratory syndrome | Metformin (NPC230775) | NP level |
| NCT01205672 | Evaluation of the Molecular Effects of Metformin on the Endometrium in Patients With Endometrial Cancer | endometrial cancer | Metformin (NPC230775) | NP level |
| NCT01068717 | Bioequivalence Study of 2.5-mg Saxagliptin and 500-mg Glucophage in Tablets and a Fixed-dose Combination Tablet in Healthy Participants | type 2 diabetes mellitus | Metformin (NPC230775) | NP level |
| NCT00454233 | A Safety and Efficacy Study With YM543 in Type 2 Diabetes Mellitus Subjects | type 2 diabetes mellitus | Metformin (NPC230775) | NP level |
| NCT01877564 | A Randomized Pilot Study to Evaluate the Effects of a Short Course of Metformin Versus No Therapy in the Period Prior to Hysterectomy for Grade 1-2 Adenocarcinoma of the Endometrium in Obese Non-Diabetic Women | adenocarcinoma | Metformin (NPC230775) | NP level |
| NCT05298670 | Drug Repurposing Using Metformin for Improving the Therapeutic Outcome in Multiple Sclerosis Patients | multiple sclerosis | Metformin (NPC230775) | NP level |
| NCT00313313 | A Study of Saxagliptin in Subjects With Type 2 Diabetes Who Have Inadequate Blood Sugar Control With Sulfonylureas | diabetes mellitus | Metformin (NPC230775) | NP level |
| NCT03006172 | To Evaluate the Safety, Tolerability, and Pharmacokinetics of Inavolisib Single Agent in Participants With Solid Tumors and in Combination With Endocrine and Targeted Therapies in Participants With Breast Cancer | breast cancer | Metformin (NPC230775) | NP level |
| NCT01814748 | A Study of the Safety and Efficacy of Omarigliptin (MK-3102) in ≥18 and <45 Year-Old Participants With Type 2 Diabetes Mellitus and Inadequate Glycemic Control (MK-3102-028) | diabetes mellitus | Metformin (NPC230775) | NP level |
| NCT00744367 | A Study of Taspoglutide Versus Placebo for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Plus Pioglitazone. | type 2 diabetes mellitus | Metformin (NPC230775) | NP level |
| NCT00283816 | Impact of Metformin in Teens With Polycystic Ovary Syndrome (PCOS) on Oral Contraceptive Therapy | polycystic ovary syndrome | Metformin (NPC230775) | NP level |
| NCT04170959 | The Addition of Metformin to Definitive Radiotherapy in Patients With Stage III NSCLC | non-small cell lung carcinoma | Metformin (NPC230775) | NP level |
| NCT00722371 | MK0431 and Pioglitazone Co-Administration Factorial Study in Patients With Type 2 Diabetes Mellitus (0431-102 AM2) | type 2 diabetes mellitus | Metformin (NPC230775) | NP level |
| NCT01796028 | Metformin-Docetaxel Association in Metastatic Hormone-refractory Prostate Cancer | prostate adenocarcinoma | Metformin (NPC230775) | NP level |
| NCT01465113 | Vitamin D Supplementation on 15-Prostaglandin Dehydrogenase Expression in Barrett's Esophagus | Barrett's esophagus | Metformin (NPC230775) | NP level |
| NCT00631488 | A Study to Test the Effectiveness and Safety of MK0893 in Combination With Other Drugs Used to Treat Type 2 Diabetes (0893-015) | type 2 diabetes mellitus | Metformin (NPC230775) | NP level |
| NCT01459809 | Efficacy and Safety Comparison of Metformin/Glimepiride Combination Versus Each Compound Alone in New Diagnosed Type 2 Diabetes Patients | type 2 diabetes mellitus | Metformin (NPC230775) | NP level |
| NCT04767841 | The AMPK Modulator Metformin as a Novel Adjunct to Conventional Therapy in Patients With Knee Osteoarthritis | osteoarthritis | Metformin (NPC230775) | NP level |
| NCT01627067 | Exemestane-RAD001-Metformin | breast cancer | Metformin (NPC230775) | NP level |
| NCT04998032 | A Study of Efficacy and Safety of Supaglutide in Type 2 Diabetes Patients On Metformin Treatment | diabetes mellitus | Metformin (NPC230775) | NP level |
| NCT02580331 | 1% Metformin Gel in the Treatment of Class II Furcation Defects | periodontitis | Metformin (NPC230775) | NP level |
| NCT02149459 | Treatment of Recurrent Brain Tumors: Metabolic Manipulation Combined With Radiotherapy | brain neoplasm | Metformin (NPC230775) | NP level |
| NCT00432276 | Efficacy of Alogliptin and Pioglitazone in Subjects With Type 2 Diabetes Mellitus | diabetes mellitus | Metformin (NPC230775) | NP level |
| NCT00885378 | Efficacy and Safety Study of Saxagliptin + Metformin Immediate Release (IR) Versus Metformin IR Alone in Type 2 Diabetes Mellitus | type 2 diabetes mellitus | Metformin (NPC230775) | NP level |
| NCT01396564 | Pioglitazone and Metformin in Diabetic Children | type 2 diabetes mellitus | Metformin (NPC230775) | NP level |
| NCT01352026 | Evaluation of Metformin Activity in Addition to Conventional Treatment of Grade II or III Pulmonary Arterial Hypertension (PAH) | pulmonary arterial hypertension | Metformin (NPC230775) | NP level |
| NCT03600363 | A Clinical Trial of Metformin in the Maintenance of Non-Hodgkin's Lymphoma Patients | diffuse large B-cell lymphoma;follicular lymphoma | Metformin (NPC230775) | NP level |
| NCT01204775 | Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacokinetics of Saxagliptin as Monotherapy in Pediatric Patients With Type 2 Diabetes | type 2 diabetes mellitus | Metformin (NPC230775) | NP level |
| NCT02497638 | LIpitor and biGuanide to Androgen Delay Trial | prostate cancer | Metformin (NPC230775) | NP level |
| NCT00528879 | A Phase III Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes Who Are Not Well Controlled on Metformin Alone | type 2 diabetes mellitus | Metformin (NPC230775) | NP level |
| NCT02249910 | Investigating the Influence of Oral Semaglutide on Pharmacokinetics of Metformin and Digoxin in Healthy Subjects | diabetes mellitus | Metformin (NPC230775) | NP level |
| NCT02949700 | Phase I/II Study OF Metformin in Combination With Cisplatin and Radiation in Head and Neck Squamous Cell Carcinoma | head and neck squamous cell carcinoma | Metformin (NPC230775) | NP level |
| NCT04275713 | Altered Tumor Oxygenation by Metformin, a Potential Step in Overcoming Radiotherapy Resistance in LACC | cervical cancer | Metformin (NPC230775) | NP level |
| NCT00690456 | Effect of Rimonabant and Metformin Combination on Glycemic Control in Patients With Type 2 Diabetes | type 2 diabetes mellitus | Metformin (NPC230775) | NP level |
| NCT01192139 | Bioequivalence Study of the Fixed Dose Combination of 5 mg Saxagliptin and 500 mg Metformin XR Tablet (Manufactured in Mt Vernon, IN) Relative to 5 mg Saxagliptin Tablet and 500 mg Metformin XR Tablet (Manufactured in Evansville, IN) | diabetes mellitus | Metformin (NPC230775) | NP level |
| NCT04581447 | Extending Time Without Diabetes After Bariatric Surgery: a Trial Comparing the Metformin Addition or Not to Standard Care | diabetes mellitus | Metformin (NPC230775) | NP level |
| NCT02437812 | Study of Paclitaxel, Carboplatin and Oral Metformin in the Treatment of Advanced Stage Ovarian Carcinoma | ovarian carcinoma | Metformin (NPC230775) | NP level |
| NCT03479476 | A Trial of Metformin in Individuals With Fragile X Syndrome | fragile X syndrome;Intellectual disability;neurobehavioral manifestations;sex chromosome disorder of sex development | Metformin (NPC230775) | NP level |
| NCT00362440 | Combination of Insulin Sensitizer and Leptin as Treatment for the HAART -Induced Metabolic Syndrome | HIV-Associated Lipodystrophy Syndrome | Metformin (NPC230775) | NP level |
| NCT00715624 | GLP-1 Receptor Agonist Lixisenatide in Patients With Type 2 Diabetes for Glycemic Control and Safety Evaluation, on Top of Basal Insulin | type 2 diabetes mellitus | Metformin (NPC230775) | NP level |
| NCT04649502 | Metformin for the Treatment of Hidradenitis Suppurativa (HS) | hidradenitis suppurativa | Metformin (NPC230775) | NP level |
| NCT00499707 | Efficacy and Safety Study of Rosiglitazone/Metformin Therapy vs Rosiglitazone and Metformin in Type 2 Diabetes Subjects | type 2 diabetes mellitus | Metformin (NPC230775) | NP level |
| NCT05373680 | Efficacy and Safety of Metformin Versus Empagliflozin on Chronic Kidney Disease Progression | chronic kidney disease | Metformin (NPC230775) | NP level |
| NCT04945148 | Oxidative Phosphorylation Targeting In Malignant Glioma Using Metformin Plus Radiotherapy Temozolomide | glioblastoma multiforme | Metformin (NPC230775) | NP level |
| NCT03465345 | Study of Metformin Plus Oligomeric Procyanidin Complex for Pharmacologic Manipulation of AGE (Advanced Glycation Endproducts) Levels in Prostate Cancer Patients | prostate cancer | Metformin (NPC230775) | NP level |
| NCT04428086 | A Pharmacokinetic Interaction Study Between Apatinib and Rosuvastatin or Metformin in Solid Tumor Subjects. | neoplasm | Metformin (NPC230775) | NP level |
| NCT00976937 | 24-week Study Comparing Lixisenatide to Sitagliptin as add-on to Metformin in Obese Type 2 Diabetic Patients Younger Than 50 Years | type 2 diabetes mellitus | Metformin (NPC230775) | NP level |
| NCT01302002 | The Use of Metformin in Early Breast Cancer Patients Pre-Surgery | breast cancer | Metformin (NPC230775) | NP level |
| NCT03204071 | Locally Delivered Metformin and Aloe Vera for Treatment of Intrabody Defects in Chronic Periodontitis | periodontitis | Metformin (NPC230775) | NP level |
| NCT00151411 | Lifestyle Intervention and Metformin for Women With Polycystic Ovary Syndrome (PCOS) | polycystic ovary syndrome | Metformin (NPC230775) | NP level |
| NCT02614859 | Bicalutamide With or Without Metformin for Biochemical Recurrence in Overweight or Obese Prostate Cancer Patients | prostate carcinoma | Metformin (NPC230775) | NP level |
| NCT03243851 | Study on Low Dose Temozolomide Plus Metformin or Placebo in Patient With Recurrent or Refractory Glioblastoma | glioblastoma multiforme | Metformin (NPC230775) | NP level |
| NCT00528372 | A Phase III Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes Who Are Not Well Controlled With Diet and Exercise | type 2 diabetes mellitus | Metformin (NPC230775) | NP level |
| NCT00337610 | Sitagliptin Metformin Add-on Study in Patients With Type 2 Diabetes Mellitus | type 2 diabetes mellitus | Metformin (NPC230775) | NP level |
| NCT00081328 | Treatment Options for Type 2 Diabetes in Adolescents and Youth (TODAY) | type 2 diabetes mellitus | Metformin (NPC230775) | NP level |
| NCT00770835 | Efficacy and Safety of Pioglitazone in Treating Subjects With Vascular Complications Associated With Type 2 Diabetes Mellitus. | diabetes mellitus | Metformin (NPC230775) | NP level |
| NCT00099866 | Efficacy and Safety of Vildagliptin Compared to Metformin in Drug Naive Patients With Type 2 Diabetes | type 2 diabetes mellitus | Metformin (NPC230775) | NP level |
| NCT01650506 | Study of Erlotinib and Metformin in Triple Negative Breast Cancer | breast cancer | Metformin (NPC230775) | NP level |
| NCT00605475 | Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ACZ885 in Patients With Type 2 Diabetes | type 2 diabetes mellitus | Metformin (NPC230775) | NP level |
| NCT01154348 | Study to Assess Safety and Pharmacokinetics of Double-Blind S-707106 Alone and in Combination With Open-Label Metformin in Patients With Type 2 Diabetes Mellitus | type 2 diabetes mellitus | Metformin (NPC230775) | NP level |
| NCT03056274 | Metformin in Intrahepatic Cholestasis of Pregnancy | pregnancy | Metformin (NPC230775) | NP level |
| NCT01483560 | REducing With MetfOrmin Vascular Adverse Lesions in Type 1 Diabetes (REMOVAL) | type 1 diabetes mellitus | Metformin (NPC230775) | NP level |
| NCT00379769 | RECORD: Rosiglitazone Evaluated for Cardiac Outcomes and Regulation of Glycaemia in Diabetes | type 2 diabetes mellitus | Metformin (NPC230775) | NP level |
| NCT03076281 | Metformin Hydrochloride and Doxycycline in Treating Patients With Head and Neck Squamous Cell Carcinoma That Can Be Removed by Surgery | oral squamous cell carcinoma | Metformin (NPC230775) | NP level |
| NCT01472367 | A Pooled Analysis of the Safety and Efficacy of MK-0431A and MK-0431A XR in Pediatric Participants With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin Therapy (Alone or in Combination With Insulin) (MK-0431A-170/MK-0431A-289) | type 2 diabetes mellitus | Metformin (NPC230775) | NP level |
| NCT00971659 | Adjunctive Therapy of Exenatide or Sitagliptin to Insulin Glargine in Type 2 Diabetes | type 2 diabetes mellitus | Metformin (NPC230775) | NP level |
| NCT01464437 | AMG 151 Amgen Protocol Number 20100761 | diabetes mellitus | Metformin (NPC230775) | NP level |
| NCT04248998 | Calorie Restriction With or Without Metformin in Triple Negative Breast Cancer | triple-negative breast cancer | Metformin (NPC230775) | NP level |
| NCT00525330 | A Randomized, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of KRP-104 in Patients With Type 2 Diabetes Inadequately Controlled on Metformin Alone | type 2 diabetes mellitus | Metformin (NPC230775) | NP level |
| NCT01064687 | A Study in Participants With Type 2 Diabetes Mellitus | type 2 diabetes mellitus | Metformin (NPC230775) | NP level |
| NCT03320694 | Comparison of Metformin and Insulin for Management of Gestational Diabetes Mellitus | gestational diabetes | Metformin (NPC230775) | NP level |
| NCT04615351 | A Pragmatic Approach to Lowering the Risk of Diabetes Mellitus After A Diagnosis of Gestational Diabetes Mellitus | gestational diabetes | Metformin (NPC230775) | NP level |
| NCT02488564 | A Study of Liposomal Doxorubicin + Docetaxel + Trastuzumab + Metformin in Operable and Locally Advanced HER2 Positive Breast Cancer | breast cancer | Metformin (NPC230775) | NP level |
| NCT02659306 | Metformin Immunotherapy in HIV Infection | HIV infection | Metformin (NPC230775) | NP level |
| NCT00792935 | A Study to Test MK-0941 in Patients With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin (MK-0941-017) | type 2 diabetes mellitus | Metformin (NPC230775) | NP level |
| NCT03259919 | Metformin Treatment of Pregnant Women With Polycystic Ovary Syndrome: a Pilot Study | polycystic ovary syndrome | Metformin (NPC230775) | NP level |
| NCT01324180 | Vincristine, Dexamethasone, Doxorubicin, and PEG-asparaginase (VPLD) and Metformin for Relapsed Childhood Acute Lymphoblastic Leukemia (ALL) | acute lymphoblastic leukemia | Metformin (NPC230775) | NP level |
| NCT02778776 | Combination of Metformine/Inulin Versus Metformin on Prostate Benign Hyperplasia in Metabolic Syndrome | metabolic syndrome | Metformin (NPC230775) | NP level |
| NCT03135301 | Letrozole in Clomiphene Resistant Infertile Women With Polycystic Ovarian Syndrome | infertility | Metformin (NPC230775) | NP level |
| NCT00789035 | 12 Weeks Treatment With 3 Different Doses of BI 10773 in Type 2 Diabetic Patients | type 2 diabetes mellitus | Metformin (NPC230775) | NP level |
| NCT01068730 | Bioequivalence Study of 500 mg and 1000 mg Glucophage (Metformin) Tablets in Healthy Subjects | type 2 diabetes mellitus | Metformin (NPC230775) | NP level |
| NCT01137812 | The CANTATA-D2 Trial (CANagliflozin Treatment And Trial Analysis - DPP-4 Inhibitor Second Comparator Trial) | type 2 diabetes mellitus | Metformin (NPC230775) | NP level |
| NCT00425009 | Therapeutic Effects of Berberine in Patients With Type 2 Diabetes | type 2 diabetes mellitus | Metformin (NPC230775) | NP level |
| NCT04148183 | Effect of Metformin and Rosiglitazone Over no Diabetic With Metabolic Syndrome Patients. | insulin resistance | Metformin (NPC230775) | NP level |
| NCT01111955 | Safety Study of BMS-823778 in Subjects With Type 2 Diabetes | type 2 diabetes mellitus | Metformin (NPC230775) | NP level |
| NCT01076088 | Safety and Efficacy of Co-Administration of Sitagliptin and Metformin in China (MK-0431-121) | type 2 diabetes mellitus | Metformin (NPC230775) | NP level |
| NCT00855166 | Evaluation of the Effect of Dapagliflozin in Combination With Metformin on Body Weight in Subjects With Type 2 Diabetes | type 2 diabetes mellitus | Metformin (NPC230775) | NP level |
| NCT02903511 | Feasibility Study of Metformin Therapy in ADPKD | Autosomal dominant polycystic kidney disease | Metformin (NPC230775) | NP level |
| NCT02190838 | Comparison of Melatonin or Metformin and Dacarbazine Combination Versus Dacarbazine Alone in Disseminated Melanoma | melanoma | Metformin (NPC230775) | NP level |
| NCT01302145 | Drug to Drug Interaction Study With ASP1941 and Metformin | type 2 diabetes mellitus | Metformin (NPC230775) | NP level |
| NCT00382096 | Efficacy of Fixed Combination Therapy of Vildagliptin and Metformin Compared to the Individual Monotherapy Components in Drug Naive Patients With Type 2 Diabetes | type 2 diabetes mellitus | Metformin (NPC230775) | NP level |
| NCT00901979 | A 12 Week Study in Patients With Type 2 Diabetes Mellitus (T2DM) | type 2 diabetes mellitus | Metformin (NPC230775) | NP level |
| NCT01529593 | Temsirolimus in Combination With Metformin in Patients With Advanced Cancers | cancer | Metformin (NPC230775) | NP level |
| NCT00401973 | Assessment of Safety and Efficacy of Therapy for the Prevention of Weight Gain Associated With Olanzapine | schizoaffective disorder;schizophrenia | Metformin (NPC230775) | NP level |
| NCT00348725 | Acceptability of a Fixed Combination of Fenofibrate and Metformin | metabolic disease | Metformin (NPC230775) | NP level |
| NCT03490019 | Treatment of Bardet-Biedl-Syndrome With Metformin for Evaluation of a Possible Visual Improvement | Bardet-Biedl syndrome;blindness (disorder) | Metformin (NPC230775) | NP level |
| NCT01095666 | A Phase III Study of BMS-512148 (Dapagliflozin) in Asian Patients With Type 2 Diabetes Who Are Not Well Controlled on Metformin Alone | type 2 diabetes mellitus | Metformin (NPC230775) | NP level |
| NCT01874080 | Bioequivalence Study | diabetes mellitus | Metformin (NPC230775) | NP level |
| NCT03204058 | Locally Delivered Metformin & Rosuvastatin for Treatment of Intrabony Defects in Chronic Periodontitis | periodontitis | Metformin (NPC230775) | NP level |
| NCT01051011 | A Study to Compare Taspoglutide and Insulin Glargine in Insulin-Naïve Patients With Type 2 Diabetes Mellitus Inadequately Controlled on Metformin and Sulfonylurea Combination Therapy | type 2 diabetes mellitus | Metformin (NPC230775) | NP level |
| NCT00881530 | Empagliflozin (BI 10773) in Type Two Diabetes (T2D) Patients, Open Label Extension | type 2 diabetes mellitus | Metformin (NPC230775) | NP level |
| NCT00482729 | MK0431A Comparative Study in Patients With Type 2 Diabetes (0431A-079)(COMPLETED) | type 2 diabetes mellitus | Metformin (NPC230775) | NP level |
| NCT01613755 | Metformin-Dipyridamole Interaction Trial | diabetes mellitus | Metformin (NPC230775) | NP level |
| NCT00672386 | A Study of the Safety and Effectiveness of a R256918 in Patients With Type 2 Diabetes | type 2 diabetes mellitus | Metformin (NPC230775) | NP level |
| NCT00121667 | Study Assessing Saxagliptin Treatment In Type 2 Diabetic Subjects Who Are Not Controlled With Metformin Alone | type 2 diabetes mellitus | Metformin (NPC230775) | NP level |
| NCT01462266 | Study of Sitagliptin for the Treatment of Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Insulin (MK-0431-260) | type 2 diabetes mellitus | Metformin (NPC230775) | NP level |
| NCT02587741 | Comparison of Diabetes Retinopathy Among Type 2 Diabetic Patients Treated With Different Regimens | diabetic retinopathy | Metformin (NPC230775) | NP level |
| NCT00909506 | Efficacy and Safety of Adjuvant Metformin for Operable Breast Cancer Patients | breast cancer | Metformin (NPC230775) | NP level |
| NCT01368081 | Empagliflozin (BI 10773) Comprehensive add-on Study in Japanese Subjects With Type 2 Diabetes Mellitus | type 2 diabetes mellitus | Metformin (NPC230775) | NP level |
| NCT04867252 | Effects of Combined Resveratrol and Myo-inositol on Altered Metabolic, Endocrine Parameters and Perceived Stress in Patients With Polycystic Ovarian Syndrome | polycystic ovary syndrome | Metformin (NPC230775) | NP level |
| NCT04852510 | Amelioration of Polycystic Ovary Syndrome Related Disorders by Supplementation of Thymoquinone and Metformin | polycystic ovary syndrome | Metformin (NPC230775) | NP level |
| NCT00809536 | Investigation Of How PD 0332334 And Metformin Are Eliminated From The Body When They Are Administered At The Same Time | generalized anxiety disorder | Metformin (NPC230775) | NP level |
| NCT02473094 | Neoadjuvant Metformin in Association to Chemoradiotherapy for Locally Advanced Rectal Cancer | rectum cancer | Metformin (NPC230775) | NP level |
| NCT01217892 | Evaluation of Dapagliflozin Taken Twice-daily | type 2 diabetes mellitus | Metformin (NPC230775) | NP level |
| NCT01076075 | A Study to Evaluate the Safety and Efficacy of Sitagliptin 100 mg in Participants With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control (MK-0431-229) | type 2 diabetes mellitus | Metformin (NPC230775) | NP level |
| NCT00713830 | GLP-1 Receptor Agonist Lixisenatide in Patients With Type 2 Diabetes for Glycemic Control and Safety Evaluation, on Top of Sulfonylurea | type 2 diabetes mellitus | Metformin (NPC230775) | NP level |
| NCT02562664 | Metformin Improves Clinical Pregnancy Rate in Polycystic Ovarian Syndrome Patients | polycystic ovary syndrome | Metformin (NPC230775) | NP level |
| NCT00479466 | Dose-Range Finding Study for MK0893 (0893-008) | type 2 diabetes mellitus | Metformin (NPC230775) | NP level |
| NCT01204294 | Comprehensive Add on Study in Japan | type 2 diabetes mellitus | Metformin (NPC230775) | NP level |
| NCT04750135 | Assessment of Metformin as Adjuvant Therapy in Patients With Ulcerative Colitis | ulcerative colitis | Metformin (NPC230775) | NP level |
| NCT05262257 | Evaluation and Intervention of Cognitive Function in Patients With Diabetes Mellitus. | diabetes mellitus | Metformin (NPC230775) | NP level |
| NCT00918138 | Study To Evaluate 24 Hour Blood Sugar Control (24-hour Mean Weighted Glucose) In Subjects That Are Taking Saxagliptin 5 mg Added Onto Metformin XR 1500 XR mg Compared To Subjects Taking Metformin XR 1500 mg Up-titrated To Metformin XR 2000 mg | type 2 diabetes mellitus | Metformin (NPC230775) | NP level |
| NCT02042495 | Endometrial Cancer Biomarker Changes Following Exposure to Metformin | endometrial cancer | Metformin (NPC230775) | NP level |
| NCT01620593 | Castration Compared to Castration Plus Metformin as First Line Treatment for Patients With Advanced Prostate Cancer | prostate cancer | Metformin (NPC230775) | NP level |
| NCT03086733 | Phase II Lung Metcore - Preoperative Metformin for Lung Cancer | non-small cell lung carcinoma | Metformin (NPC230775) | NP level |
| NCT00971243 | Efficacy and Safety of MP-513 in Combination With Metformin in Patients With Type 2 Diabetes | type 2 diabetes mellitus | Metformin (NPC230775) | NP level |
| NCT01292993 | A Study to Evaluate the Interaction of LX4211 and Metformin in Healthy Subjects | type 2 diabetes mellitus | Metformin (NPC230775) | NP level |
| NCT01677923 | Obesity in Children and Adolescents: Associated Risks and Early Intervention | obesity | Metformin (NPC230775) | NP level |
| NCT01046500 | Myo-inositol Versus Metformin Administration in Post-menopausal Women With Metabolic Syndrome | metabolic syndrome | Metformin (NPC230775) | NP level |
| NCT02689843 | Effects of Cyproterone Compound-spironolactone, Metformin and Pioglitazone on Inflammatory Markers in PCOS | polycystic ovary syndrome | Metformin (NPC230775) | NP level |
| NCT01864681 | Combination of Metformin With Gefitinib to Treat NSCLC | non-small cell lung carcinoma | Metformin (NPC230775) | NP level |
| NCT00763451 | GLP-1 Receptor Agonist Lixisenatide in Patients With Type 2 Diabetes for Glycemic Control and Safety Evaluation, on Top of Metformin | type 2 diabetes mellitus | Metformin (NPC230775) | NP level |
| NCT02614339 | Effect of Adjunctive Metformin on Recurrence of Non-DM Colorectal Cancer Stage II High-risk/ III Colorectal Cancer | colorectal carcinoma | Metformin (NPC230775) | NP level |
| NCT01581814 | Effects of Drospirenone-ethinylestradiol and/or Metformin on Cardiovascular Risk in Hyperinsulinemic Women With Polycystic Ovary Syndrome | polycystic ovary syndrome | Metformin (NPC230775) | NP level |
| NCT03008551 | Empagliflozin vs Metformin in PCOS | polycystic ovary syndrome | Metformin (NPC230775) | NP level |
| NCT01808690 | EMERALD: Effects of Metformin on Cardiovascular Function in Adolescents With Type 1 Diabetes | type 1 diabetes mellitus | Metformin (NPC230775) | NP level |
| NCT03764605 | Metformin vs Tolvaptan for Treatment of Autosomal Dominant Polycystic Kidney Disease | Autosomal dominant polycystic kidney disease | Metformin (NPC230775) | NP level |
| NCT04143282 | Evaluation of the Effect of Metformin on Metastatic Breast Cancer as Adjuvant Treatment | breast cancer | Metformin (NPC230775) | NP level |
| NCT00263965 | ARAMIS: Actions of tesaglitazaR on fAt Metabolism and Insulin Sensitivity | type 2 diabetes mellitus | Metformin (NPC230775) | NP level |
| NCT00263276 | A Trial of BMS-512148 in Patients With Type 2 Diabetes Mellitus | type 2 diabetes mellitus | Metformin (NPC230775) | NP level |
| NCT00683735 | Quantification of the Dipeptidyl Peptidase (DPP)-4 Inhibition-mediated Enhancement of the Activity of the Entero-insular Axis | diabetes mellitus | Metformin (NPC230775) | NP level |
| NCT02848950 | The Effect of Metformin on Fecundability in an ART(Assisted Reproductive Technology) Setting - the Correlation to Uterine Flows | infertility | Metformin (NPC230775) | NP level |
| NCT01175473 | Effects of Lixisenatide Compared to Liraglutide on the Postprandial Plasma Glucose in Patients With Type 2 Diabetes | type 2 diabetes mellitus | Metformin (NPC230775) | NP level |
| NCT02360059 | Metformin for Reduction of Paclitaxel-Related Neuropathy in Patients With Breast Cancer | breast cancer | Metformin (NPC230775) | NP level |
| NCT01340768 | Study to Compare Sitagliptin Versus Sulfonylurea Treatment During Ramadan Fasting in Patients With Type 2 Diabetes (MK-0431-262) | type 2 diabetes mellitus | Metformin (NPC230775) | NP level |
| NCT00611884 | Comparison of Two NN1250 Formulations Versus Insulin Glargine, All in Combination With Metformin in Subjects With Type 2 Diabetes | type 2 diabetes mellitus | Metformin (NPC230775) | NP level |
| NCT00734474 | A Study of LY2189265 Compared to Sitagliptin in Participants With Type 2 Diabetes Mellitus on Metformin | type 2 diabetes mellitus | Metformin (NPC230775) | NP level |
| NCT00754689 | Study of Rimonabant/Metformin Combinations to Investigate Diabetes (Blood Sugar) Control in Patients With Type 2 Diabetes | type 2 diabetes mellitus | Metformin (NPC230775) | NP level |
| NCT04780854 | Drug Repurposing for the Prevention of Chemotherapy-induced Peripheral Neuropathy (CIPN) | peripheral neuropathy | Metformin (NPC230775) | NP level |
| NCT03349775 | Cardiometabolic Disease and Pulmonary Hypertension | obesity | Metformin (NPC230775) | NP level |
| NCT03651895 | Metformin to Reduce Airway Glucose in COPD Patients | chronic obstructive pulmonary disease | Metformin (NPC230775) | NP level |
| NCT01310231 | A Trial of Standard Chemotherapy With Metformin (vs Placebo) in Women With Metastatic Breast Cancer | breast cancer | Metformin (NPC230775) | NP level |
| NCT04899349 | Study of Safety and Efficacy of Dapagliflozin + Metformin XR Versus Metformin XR in Participants With HR+, HER2-, Advanced Breast Cancer While on Treatment With Alpelisib and Fulvestrant | breast cancer | Metformin (NPC230775) | NP level |
| NCT01106625 | The CANTATA-MSU Trial (CANagliflozin Treatment And Trial Analysis - Metformin and SUlphonylurea) | type 2 diabetes mellitus | Metformin (NPC230775) | NP level |
| NCT05349474 | Metformin Treatment in Progressive Multiple Sclerosis | primary progressive multiple sclerosis;secondary progressive multiple sclerosis | Metformin (NPC230775) | NP level |
| NCT03054519 | Improve PAD PERformance With METformin | peripheral arterial disease | Metformin (NPC230775) | NP level |
| NCT00295633 | A Study Assessing Saxagliptin Treatment in Type 2 Diabetic Subjects Who Are Not Controlled With TZD Therapy Alone | type 2 diabetes mellitus | Metformin (NPC230775) | NP level |
| NCT01890122 | Efficacy and Safety of Alogliptin and Metformin Fixed-Dose Combination in Participants With Type 2 Diabetes | diabetes mellitus | Metformin (NPC230775) | NP level |
| NCT01566799 | Metformin Plus Neoadjuvant Chemotherapy in Breast Cancer | neoplasm | Metformin (NPC230775) | NP level |
| NCT00086502 | Pioglitazone Add-on Study in Patients With Type 2 Diabetes Mellitus | type 2 diabetes mellitus | Metformin (NPC230775) | NP level |
| NCT01217073 | A Dose-Range Finding Study in Participants With Type 2 Diabetes (MK-3102-006) | type 2 diabetes mellitus | Metformin (NPC230775) | NP level |
| NCT02819869 | The Combination Effect of Statin Plus Metformin on Relapse-free | hepatocellular carcinoma | Metformin (NPC230775) | NP level |
| NCT00038727 | Diabetes Prevention Program Outcomes Study | diabetes mellitus | Metformin (NPC230775) | NP level |
| NCT04691960 | A Pilot Study of Ketogenic Diet and Metformin in Glioblastoma: Feasibility and Metabolic Imaging | glioblastoma multiforme | Metformin (NPC230775) | NP level |
| NCT02360618 | Metformin and Simvastatin Use in Bladder Cancer | urinary bladder cancer | Metformin (NPC230775) | NP level |
| NCT02402348 | Pilot Study of Metformin in HNSCC to Investigate the Effects of MF, Tumor Genotype and MF-genotype Interactions, on Tumor Metabolism and Anoikis | head and neck malignant neoplasia | Metformin (NPC230775) | NP level |
| NCT00106340 | Vildagliptin Compared to Glimepiride in Combination With Metformin in Patients With Type 2 Diabetes | type 2 diabetes mellitus | Metformin (NPC230775) | NP level |
| NCT00063635 | Treatment of Nonalcoholic Fatty Liver Disease in Children (TONIC) | Hepatic steatosis | Metformin (NPC230775) | NP level |
| NCT05132439 | MetfOrmin BenefIts Lower Extremities With Intermittent Claudication | intermittent vascular claudication | Metformin (NPC230775) | NP level |
| NCT01482286 | Effect of Weight and Insulin Sensitivity on Reproductive Function in PCOS | polycystic ovary syndrome | Metformin (NPC230775) | NP level |
| NCT00032487 | Glycemic Control and Complications in Diabetes Mellitus Type 2 (VADT) | type 2 diabetes mellitus | Metformin (NPC230775) | NP level |
| NCT00332488 | Efficacy and Safety of Prandial Inhalation of Technosphere/Insulin in Combination With Metformin or Technosphere/Insulin Alone Versus 2 Oral Anti-Diabetic Agents in Subjects With Type 2 Diabetes | type 2 diabetes mellitus | Metformin (NPC230775) | NP level |
| NCT01023581 | Efficacy and Safety of Alogliptin Plus Metformin in Patients With Type 2 Diabetes | type 2 diabetes mellitus | Metformin (NPC230775) | NP level |
| NCT02018731 | L-citrulline and Metformin in Becker's Muscular Dystrophy | muscular dystrophy | Metformin (NPC230775) | NP level |
| NCT00924573 | Comparative Study of HOE490 O (Glimepiride and Metformin) Compared With Placebo on Top of Glimepiride | type 2 diabetes mellitus | Metformin (NPC230775) | NP level |
| NCT00875394 | Study to Assess the Efficacy and Safety of Sitagliptin Added to the Regimen of Patients With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin (0431-189) | type 2 diabetes mellitus | Metformin (NPC230775) | NP level |
| NCT03651531 | Comparison of Insulin Alone to Insulin With Metformin to Treat Gestational Diabetes Mellitus | gestational diabetes | Metformin (NPC230775) | NP level |
| NCT00251953 | GALLANT 8 Tesaglitazar Add-on to Metformin | type 2 diabetes mellitus | Metformin (NPC230775) | NP level |
| NCT03108963 | L-carnitine and Metformin in Obese PCOS Women. | polycystic ovary syndrome | Metformin (NPC230775) | NP level |
| NCT02461667 | Alendronate Compared to Metformin in Chronic Periodontitis | periodontitis | Metformin (NPC230775) | NP level |
| NCT01578551 | Study of Metformin Plus Paclitaxel/Carboplatin/Bevacizumab in Patients With Adenocarcinoma. | lung adenocarcinoma | Metformin (NPC230775) | NP level |
| NCT00839527 | A Study to Determine the Safety and Efficacy of Albiglutide in Subjects With Type 2 Diabetes | type 2 diabetes mellitus | Metformin (NPC230775) | NP level |
| NCT00316082 | Study of BMS-477118 as Monotherapy With Titration in Subjects With Type 2 Diabetes Who Are Not Controlled With Diet and Exercise | diabetes mellitus | Metformin (NPC230775) | NP level |
| NCT00069836 | Study Of AVANDAMET® With Or Without Insulin In Type II Diabetes Mellitus Patients. AVANDAMET® is a Registered Trademark of the GSK Group of Companies. | type 2 diabetes mellitus | Metformin (NPC230775) | NP level |
| NCT00316758 | A Study to Evaluate the Long-Term Safety and Tolerability of GK Activator (2) in Patients With Type 2 Diabetes. | type 2 diabetes mellitus | Metformin (NPC230775) | NP level |
| NCT04141163 | Metformin in Patients With Fragile X | fragile X syndrome | Metformin (NPC230775) | NP level |
| NCT00519480 | A Study To Assess The Safety And Tolerability Of GSK189075 When Given With A Total Daily Dose Of >/ 2000mg of Metformin | type 2 diabetes mellitus | Metformin (NPC230775) | NP level |
| NCT02472353 | Use of Metformin to Reduce Cardiac Toxicity in Breast Cancer | breast cancer | Metformin (NPC230775) | NP level |
| NCT02086526 | Targeting Pathways in Polycystic Ovary Syndrome (PCOS) Using Metformin (MET) | polycystic ovary syndrome | Metformin (NPC230775) | NP level |
| NCT00971295 | Effect of Eslicarbazepine Acetate on the Pharmacokinetics of Metformin in Healthy Volunteers | neuropathic pain | Metformin (NPC230775) | NP level |
| NCT03236662 | (-)- Epicatechin Becker Muscular Dystrophy | Becker muscular dystrophy | (-)-Epicatechin (NPC126029) | NP level |
| NCT00344851 | Exenatide and Metformin Therapy in Overweight Women With PCOS | polycystic ovary syndrome | Metformin (NPC230775) | NP level |
| NCT00820573 | Mechanisms of Glucose Lowering Effects of Sitagliptin and Metformin Alone and in Combination in Patients With T2DM | diabetes mellitus | Metformin (NPC230775) | NP level |
| NCT01856868 | Use of (-)-Epicatechin in the Treatment of Becker Muscular Dystrophy (Pilot Study) | Becker muscular dystrophy | (-)-Epicatechin (NPC126029) | NP level |
| NCT01059825 | Study Of Safety And Efficacy Of Ertugliflozin (PF-04971729, MK-8835) In Participants With Type 2 Diabetes (MK-8835-016) | type 2 diabetes mellitus | Metformin (NPC230775) | NP level |
| NCT04088448 | The Antidiabetic Metformin as a Novel Adjunct to Antidepressants in Major Depressive Disorder Patients | major depressive disorder | Metformin (NPC230775) | NP level |
| NCT00959101 | Comparison of Repaglinide and Metformin Combination Tablet Versus Repaglinide and Metformin as Separate Tablets in Healthy Volunteers | diabetes mellitus | Metformin (NPC230775) | NP level |
| NCT00272064 | ELEONOR STUDY: Insulin Glulisine in Type 2 Diabetes Mellitus. | type 2 diabetes mellitus | Metformin (NPC230775) | NP level |
| NCT01135433 | A Study to Assess the Efficacy and Safety of ASP1941 in Combination With Metformin in Type 2 Diabetic Patients | type 2 diabetes mellitus | Metformin (NPC230775) | NP level |
| NCT05236530 | Drug-drug Interaction Study of Ganaplacide and Lumefantrine With Midazolam, Repaglinide, Dextromethorphan, Metformin, Rosuvastatin and Dolutegravir | malaria | Metformin (NPC230775) | NP level |
| NCT01245166 | A Phase III Randomized, Double-blind, Parallel-group Study to Evaluate the Efficacy and Safety of Acarmet (Metformin HCl 500 mg Plus Acarbose 50 mg Tablets) Versus Acarbose Alone in Subjects With Type 2 Diabetes Mellitus | type 2 diabetes mellitus | Metformin (NPC230775) | NP level |
| NCT01733459 | Efficacy and Safety of DLBS3233 in Subjects With Polycystic Ovary Syndrome (PCOS) | polycystic ovary syndrome | Metformin (NPC230775) | NP level |
| NCT05131828 | CCMR Two: A Phase IIa, Randomised, Double-blind, Placebo-controlled Trial of the Ability of the Combination of Metformin and Clemastine to Promote Remyelination in People With Relapsing-remitting Multiple Sclerosis Already on Disease-modifying Therapy | multiple sclerosis | Metformin (NPC230775) | NP level |
| NCT04826692 | TEsting METformin Against Cognitive Decline in HD | Huntington disease | Metformin (NPC230775) | NP level |
| NCT01405118 | Effect Of CP-690,550 On The Pharmacokinetics Of Metformin In Healthy Volunteers | rheumatoid arthritis | Metformin (NPC230775) | NP level |
| NCT01685762 | Metformin for the Treatment of Endometrial Hyperplasia | endometrial hyperplasia | Metformin (NPC230775) | NP level |
| NCT01995032 | L-citrulline and Metformin in Duchenne's Muscular Dystrophy | muscular dystrophy | Metformin (NPC230775) | NP level |
| NCT01318135 | Long-term Safety Study of Alogliptin Used in Combination With Sulfonylurea or Metformin in Participants With Type 2 Diabetes in Japan | type 2 diabetes mellitus | Metformin (NPC230775) | NP level |
| NCT00698230 | Safety and Efficacy of INCB013739 Plus Metformin Compared to Metformin Alone on Glycemic Control in Type 2 Diabetics | type 2 diabetes mellitus | Metformin (NPC230775) | NP level |
| NCT04068246 | The AMPK Modulator Metformin as a Novel Adjunct to Conventional Therapy in Rheumatoid Arthritis Patients | rheumatoid arthritis | Metformin (NPC230775) | NP level |
| NCT00184574 | Comparison of Biphasic Insulin Aspart 70/30, 50/50, and 30/70 in Subjects With Type 2 Diabetes | type 2 diabetes mellitus | Metformin (NPC230775) | NP level |
| NCT00097279 | Comparison of Biphasic Insulin Aspart 70/30 With Anti-Diabetic Drugs in Subjects With Type 2 Diabetes | type 2 diabetes mellitus | Metformin (NPC230775) | NP level |
| NCT00046462 | Determine Whether Glycemic Control is Different Between Lantus & a 3rd Oral Agent When Failure With Other Treatment | diabetes mellitus | Metformin (NPC230775) | NP level |
| NCT01638676 | A Phase I/II Trial of Vemurafenib and Metformin to Melanoma Patients | melanoma | Metformin (NPC230775) | NP level |
| NCT00968812 | CANagliflozin Treatment And Trial Analysis-Sulfonylurea (CANTATA-SU) SGLT2 Add-on to Metformin Versus Glimepiride | type 2 diabetes mellitus | Metformin (NPC230775) | NP level |
| NCT01477060 | Modulation of Response to Hormonal Therapy With Lapatinib and/or Metformin in Patients With Metastatic Breast Cancer | breast cancer | Metformin (NPC230775) | NP level |
| NCT03824002 | Dulaglutide in Diabetic Patients, Relationship Between Arterial Stiffness, Endothelial Function, Clinical and Laboratory Variables | diabetes mellitus | Metformin (NPC230775) | NP level |
| NCT02629627 | Conjugated Linoleic Acid / Leucine Versus Metformin on Visceral Fat in Metabolic Syndrome | metabolic syndrome | Metformin (NPC230775) | NP level |
| NCT02531308 | Metformin in Combination With Standard Induction Therapy for Large B-cell Lymphoma (DLBCL) | diffuse large B-cell lymphoma | Metformin (NPC230775) | NP level |
| NCT00941382 | Sibutramine-metformin Combination Versus Sibutramine and Metformin Monotherapy in Obese Patients | obesity | Metformin (NPC230775) | NP level |
| NCT00631033 | DZX Mediated Insulin Suppression in Obese Men | obesity | Metformin (NPC230775) | NP level |
| NCT02064374 | Effect of Dolutegravir on Metformin Pharmacokinetics in Healthy Adult Subjects | HIV infection | Metformin (NPC230775) | NP level |
| NCT00131664 | Avandia™ + Amaryl™ or Avandamet™ Compared With Metformin (AVALANCHE™ Study) | type 2 diabetes mellitus | Metformin (NPC230775) | NP level |
| NCT02244567 | Effect of Metformin Therapy on Serum Under-carboxylated Osteocalcin Levels in Hyperandrogenic Lean Polycystic Ovarian Syndrome Women | polycystic ovary syndrome | Metformin (NPC230775) | NP level |
| NCT01002807 | Bioavailability Study of Fixed Dose Combination (FDC) Formulations of Dapagliflozin and Metformin XR Versus Individual Component Coadministered to Healthy Subjects in a Fasted State | type 2 diabetes mellitus | Metformin (NPC230775) | NP level |
| NCT00086515 | Metformin Add-on Study in Patients With Type 2 Diabetes Mellitus (0431-020)(COMPLETED) | type 2 diabetes mellitus | Metformin (NPC230775) | NP level |
| NCT01075282 | A Study in Participants With Type 2 Diabetes Mellitus (AWARD-2) | type 2 diabetes mellitus | Metformin (NPC230775) | NP level |
| NCT00613951 | Comparison of Two NN5401 Formulations Versus Biphasic Insulin Aspart 30, All in Combination With Metformin in Subjects With Type 2 Diabetes | type 2 diabetes mellitus | Metformin (NPC230775) | NP level |
| NCT00544518 | Impact of Benfluorex Versus Metformin on Glucose Control and Insulin Secretion in Chinese Type 2 Diabetic Patients | type 2 diabetes mellitus | Metformin (NPC230775) | NP level |
| NCT01816659 | An Open-Labeled Pilot Study of Biomarker Response Following Short-Term Exposure to Metformin | colorectal carcinoma | Metformin (NPC230775) | NP level |
| NCT00868790 | A Study of the Safety and Efficacy of MK-3577 in Participants With Type 2 Diabetes Mellitus (MK-3577-009) | type 2 diabetes mellitus | Metformin (NPC230775) | NP level |
| NCT03378297 | IMPACT: A Randomized WOO Study of Novel Therapeutic Agents in Women Triaged to Primary Surgery for EOC | ovarian cancer | Metformin (NPC230775) | NP level |
| NCT02365597 | An Efficacy and Safety Study of Erdafitinib (JNJ-42756493) in Participants With Urothelial Cancer | urogenital neoplasm | Metformin (NPC230775) | NP level |
| NCT03184493 | Celebrex and Metformin for Postoperative Hepatocellular Carcinoma | liver cancer | Metformin (NPC230775) | NP level |
| NCT01804049 | Metformin and Muscle in Insulin-resistant Older Veterans | prediabetes syndrome | Metformin (NPC230775) | NP level |
| NCT02186847 | Chemotherapy and Radiation Therapy With or Without Metformin Hydrochloride in Treating Patients With Stage III Non-small Cell Lung Cancer | bronchoalveolar adenocarcinoma;large cell lung carcinoma | Metformin (NPC230775) | NP level |
| NCT02519543 | Treating Insulin Resistance as a Strategy to Improve Outcome in Refractory Bipolar Disorder | bipolar disorder | Metformin (NPC230775) | NP level |
| NCT03862950 | A Trial of Metformin in Individuals With Fragile X Syndrome (Met) | fragile X syndrome;intellectual disability;Intellectual disability;neurobehavioral manifestations;sex chromosome disorder of sex development | Metformin (NPC230775) | NP level |
| NCT00617240 | Strategies to Reduce Antipsychotic-Associated Weight Gain in Youth | body weight gain | Metformin (NPC230775) | NP level |
| NCT02308228 | Metformin to Augment Strength Training Effective Response in Seniors (MASTERS) | aging | Metformin (NPC230775) | NP level |
| NCT02672488 | Metformin Plus Sorafenib for Advanced HCC | hepatocellular carcinoma | Metformin (NPC230775) | NP level |
| NCT01442870 | Evaluation of Clinical Safety of Combining Metformin With Anticancer Chemotherapy | cancer | Metformin (NPC230775) | NP level |
| NCT01318109 | Efficacy and Safety of Alogliptin Used Combination With Metformin in Participants With Type 2 Diabetes in Japan | type 2 diabetes mellitus | Metformin (NPC230775) | NP level |
| NCT00353691 | Glimepiride vs Metformin as Monotherapy in Pediatric Subjects With Type 2 Diabetes Mellitus | type 2 diabetes mellitus | Metformin (NPC230775) | NP level |
| NCT02755844 | Safety and Efficacy of Metronomic Cyclophosphamide, Metformin and Olaparib in Endometrial Cancer Patients | endometrial cancer | Metformin (NPC230775) | NP level |
| NCT02848508 | Metformin in Moderate and Severe Renal Failure (CKD 3-4): A Follow-up Study | chronic kidney disease | Metformin (NPC230775) | NP level |
| NCT02254512 | Metformin and Carbohydrate Restriction With Platinum Based Chemotherapy In Stage IIIB/IV Non-Squamous Non-Small Cell Lung Cancer (NS-NSCLC) | carcinoma | Metformin (NPC230775) | NP level |
| NCT00469586 | Efficacy and Safety of Inhaled Insulin Compared to Metformin and Glimepiride in Type 2 Diabetes | type 2 diabetes mellitus | Metformin (NPC230775) | NP level |
| NCT03994744 | Assessing Safety and Efficacy of Sintilimab and Metformin Combination Therapy in SCLC | small cell lung carcinoma | Metformin (NPC230775) | NP level |
| NCT01087866 | Metformin Versus Insulin in the Treatment of Gestational Diabetes Mellitus | gestational diabetes | Metformin (NPC230775) | NP level |
| NCT04607252 | Metformin Plus Megestrol Acetate as a Fertility-sparing Treatment in Patients With Atypical Endometrial Hyperplasia | endometrial hyperplasia | Metformin (NPC230775) | NP level |
| NCT01117584 | A Study to Evaluate the Effect of ASP1941 in Combination With Metformin in Adult Patients With Type 2 Diabetes Mellitus | type 2 diabetes mellitus | Metformin (NPC230775) | NP level |
| NCT00268476 | Systemic Therapy in Advancing or Metastatic Prostate Cancer: Evaluation of Drug Efficacy | prostate cancer | Metformin (NPC230775) | NP level |
| NCT01980823 | Pre-Surgical Trial of the Combination of Metformin and Atorvastatin in Newly Diagnosed Operable Breast Cancer | breast cancer | Metformin (NPC230775) | NP level |
| NCT00700817 | The Effect of Liraglutide Compared to Sitagliptin, Both in Combination With Metformin on Glycaemic Control in Subjects With Type 2 Diabetes Mellitus | type 2 diabetes mellitus | Metformin (NPC230775) | NP level |
| NCT04220021 | Safety and Therapeutic Potential of the FDA-approved Drug Metformin for C9orf72 ALS/FTD | frontotemporal dementia | Metformin (NPC230775) | NP level |
| NCT04196868 | Methotrexate and Metformin in Rheumatoid Arthritis Patients | rheumatoid arthritis | Metformin (NPC230775) | NP level |
| NCT00449605 | A Glycemic Control Evaluation of Glimepiride Versus Rimonabant on Top of Metformin in Type 2 Diabetes | type 2 diabetes mellitus | Metformin (NPC230775) | NP level |
| NCT04536805 | Relapse in Previously Irradiated Prostate Bed : Stereotactic Ablative Reirradiation Potentiated by Metformin | prostate cancer | Metformin (NPC230775) | NP level |
| NCT01095653 | A Phase III Study of BMS-512148 (Dapagliflozin) in Asian Patients With Type 2 Diabetes Who Are Not Well Controlled With Diet and Exercise | type 2 diabetes mellitus | Metformin (NPC230775) | NP level |
| NCT01370707 | A Study to Evaluate the Efficacy and Safety of CJ-30001 and CJ-30002 in Type 2 Diabetes Mellitus Patients | diabetes mellitus | Metformin (NPC230775) | NP level |
| NCT02656017 | Metformin as a Novel Therapy for Autosomal Dominant Polycystic Kidney Disease | Autosomal dominant polycystic kidney disease | Metformin (NPC230775) | NP level |
| NCT03053544 | Metformin With Neoadjuvant Chemoradiation to Improve Pathologic Responses in Rectal Cancer | rectum cancer | Metformin (NPC230775) | NP level |
| NCT01440127 | Impact of Pretreatment With Metformin on Colorectal Cancer Stem Cells (CCSC) and Related Pharmacodynamic Markers | malignant colon neoplasm | Metformin (NPC230775) | NP level |
| NCT00087516 | Monotherapy Study in Patients With Type 2 Diabetes Mellitus (0431-021) | type 2 diabetes mellitus | Metformin (NPC230775) | NP level |
| NCT05426044 | Metformin as a Neuroprotective Therapy for Glaucoma - A Randomized Controlled Trial | glaucoma | Metformin (NPC230775) | NP level |
| NCT00743002 | A Trial of TT223 in Patients With Type 2 Diabetes Who Are Taking Metformin and/or Thiazolidinedione | type 2 diabetes mellitus | Metformin (NPC230775) | NP level |
| NCT00856284 | Efficacy and Safety of Alogliptin Plus Metformin Compared to Glipizide Plus Metformin in Patients With Type 2 Diabetes Mellitus | type 2 diabetes mellitus | Metformin (NPC230775) | NP level |
| NCT03258723 | Diabetes Prevention With Lifestyle Intervention and Metformin Escalation | diabetes mellitus | Metformin (NPC230775) | NP level |
| NCT04792749 | Clinical Effects of Metformin on Fertility-sparing Treatment for Early Endometrial Cancer | endometrial cancer | Metformin (NPC230775) | NP level |
| NCT00830076 | A Study of the Effects of Co-Administration of Sitagliptin (MK-0431) and Metformin on Incretin Hormone Concentrations (MK-0431-110) | type 2 diabetes mellitus | Metformin (NPC230775) | NP level |
| NCT02115464 | Advanced Lung Cancer Treatment With Metformin and Chemo-Radiotherapy | lung cancer | Metformin (NPC230775) | NP level |
| NCT01775176 | Effect of Weight & Insulin Sensitivity on Reproductive Function in PCOS: Studies in Skeletal Muscle & Adipose | polycystic ovary syndrome | Metformin (NPC230775) | NP level |
| NCT00266253 | A Study of GK Activator (2) in Patients With Type 2 Diabetes Mellitus Treated With a Stable Dose of Metformin | type 2 diabetes mellitus | Metformin (NPC230775) | NP level |
| NCT01340664 | An Efficacy, Safety, and Tolerability Study of Canagliflozin in the Treatment of Patients With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin Monotherapy | type 2 diabetes mellitus | Metformin (NPC230775) | NP level |
| NCT01381900 | A Efficacy, Safety, and Tolerability Study of Canagliflozin in Patients With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin Alone or in Combination With a Sulphonylurea | type 2 diabetes mellitus | Metformin (NPC230775) | NP level |
| NCT01997775 | Metformin in Stage IV Lung Adenocarcinoma | non-small cell lung carcinoma | Metformin (NPC230775) | NP level |
| NCT00975052 | A Study of the Effects of Sitagliptin (MK0431) and Metformin on Incretin Hormone Concentrations (0431-050)(COMPLETED) | type 2 diabetes mellitus | Metformin (NPC230775) | NP level |
| NCT01926769 | A Phase II Study to Determine the Safety and Efficacy of Second-line Treatment With Metformin and Chemotherapy (FOLFOX6 or FOFIRI) in the Second Line Threatment of Advanced Colorectal Cancer | colorectal adenocarcinoma | Metformin (NPC230775) | NP level |
| NCT00842400 | A Drug Interaction Study of VI-0521 With Metformin, Sitagliptan and Probenecid in Healthy Subjects. | obesity | Metformin (NPC230775) | NP level |
| NCT02143050 | Study of Dabrafenib, Trametinib and Metformin for Melanoma Patients | melanoma | Metformin (NPC230775) | NP level |
| NCT03039075 | Metformin SR Tablet (DuLeNing) and Glucophage in Patients With Type 2 Diabetes | diabetes mellitus | Metformin (NPC230775) | NP level |
| NCT00860288 | Efficacy and Long-Term Safety of Vildagliptin as Add-on Therapy to Metformin in Patients With Type 2 Diabetes | type 2 diabetes mellitus | Metformin (NPC230775) | NP level |
| NCT00698789 | Evaluate the Safety and Tolerability of INCB019602 When Administered With Metformin in Patients With Type 2 Diabetes | type 2 diabetes mellitus | Metformin (NPC230775) | NP level |
| NCT00427154 | Effect of Inhaled Pre-prandial Human Insulin on Blood Glucose Control in Type 2 Diabetes | type 2 diabetes mellitus | Metformin (NPC230775) | NP level |
| NCT02040376 | Metformin for Brain Repair in Children With Cranial-Spinal Radiation for Medulloblastoma | brain neoplasm | Metformin (NPC230775) | NP level |
| NCT00067951 | A Study To Evaluate The Safety And Efficacy Of An Investigational Diabetes Drug In Poorly Controlled Type II Diabetics | type 2 diabetes mellitus | Metformin (NPC230775) | NP level |
| NCT01234649 | Combined Liraglutide and Metformin Therapy in Women With Previous Gestational Diabetes Mellitus (GDM) | abnormal glucose tolerance;metabolic syndrome | Metformin (NPC230775) | NP level |
| NCT01353391 | Metformin in Women With Type 2 Diabetes in Pregnancy Trial | type 2 diabetes mellitus | Metformin (NPC230775) | NP level |
| NCT00643851 | An Efficacy & Safety Study of BMS-512148 in Combination With Metformin Extended Release Tablets | type 2 diabetes mellitus | Metformin (NPC230775) | NP level |
| NCT05394142 | A Clinical Trial to Evaluate the Efficacy, Tolerability, and Safety of a Fixed Dose Combination of Spironolactone, Pioglitazone & Metformin (SPIOMET) in Polycystic Ovary Syndrome (PCOS) | polycystic ovary syndrome | Metformin (NPC230775) | NP level |
| NCT03674385 | Efficacy of Vit E in PCOS Resistant to Clomiphene Citrate | polycystic ovary syndrome | Metformin (NPC230775) | NP level |
| NCT00349128 | Fenofibrate in Dyslipidemia and Metformin-Controlled Diabetes | metabolic disease | Metformin (NPC230775) | NP level |
| NCT00961909 | A Study of RO5095932 in Patients With Type 2 Diabetes Mellitus | type 2 diabetes mellitus | Metformin (NPC230775) | NP level |
| NCT01042379 | I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer | angiosarcoma;triple-negative breast cancer | Metformin (NPC230775) | NP level |
| NCT02823691 | The MetNET-2 Trial | neuroendocrine neoplasm | Metformin (NPC230775) | NP level |
| NCT01561482 | Study of Metformin With Simvastatin for Men With Prostate Carcinoma | prostate carcinoma | Metformin (NPC230775) | NP level |
| NCT01840007 | Pilot Study Evaluating the Efficacy and Safety of Metformin in Melanoma | metastatic melanoma | Metformin (NPC230775) | NP level |
| NCT02019979 | Metformin and Carbohydrate Restriction With Platinum Based Chemotherapy In Stage IIIB/IV Non-Squamous Non-Small Cell Lung Cancer (NS-NSCLC) | non-small cell lung carcinoma | Metformin (NPC230775) | NP level |
| NCT03086005 | Study to Assess the Effect of Metformin Supplementation on IVF Outcome in Patients With Polycystic Ovarian Syndrome. | polycystic ovary syndrome | Metformin (NPC230775) | NP level |
| NCT00575588 | 52-week add-on to Metformin Comparison of Saxagliptin and Sulphonylurea, With a 52-week Extension Period | type 2 diabetes mellitus | Metformin (NPC230775) | NP level |
| NCT03017833 | Sapanisertib and Metformin in Treating Patients With Advanced or Metastatic Relapsed or Refractory Cancers | neoplasm | Metformin (NPC230775) | NP level |
| NCT01243385 | Metformin Hydrochloride as First-Line Therapy in Treating Patients With Locally Advanced or Metastatic Prostate Cancer | prostate cancer | Metformin (NPC230775) | NP level |
| NCT00120146 | Glaser Obesity Study | obesity | Metformin (NPC230775) | NP level |
| NCT03722290 | Metformin in Children and Adults With Fragile X Syndrome | fragile X syndrome | Metformin (NPC230775) | NP level |
| NCT01093794 | Bioequivalence Study of Sitagliptin/Metformin Combination Tablet (MK0431A-122) | type 2 diabetes mellitus | Metformin (NPC230775) | NP level |
| NCT00598793 | Biphasic Insulin Aspart 30 in Type 2 Diabetes Failing OAD Therapy | type 2 diabetes mellitus | Metformin (NPC230775) | NP level |
| NCT00383578 | Efficacy and Safety of Vildagliptin Compared to Metformin in Elderly Drug Naive Patients With Type 2 Diabetes | type 2 diabetes mellitus | Metformin (NPC230775) | NP level |
| NCT03710343 | Metformin for Motor and Cognitive Improvement in Children With Cerebral Palsy: A Feasibility Study | spastic cerebral palsy | Metformin (NPC230775) | NP level |
| NCT00261352 | GALLANT 14 Tesaglitazar vs. Metformin and Fenofibrate | type 2 diabetes mellitus | Metformin (NPC230775) | NP level |
| NCT01107717 | Durability of Combination Therapy With Exenatide/Pioglitazone/Metformin vs. Conventional Therapy in New Onset T2DM | diabetes mellitus | Metformin (NPC230775) | NP level |
| NCT04209075 | Prebiotics and Metformin Improve Gut and Hormones in Type 2 Diabetes in Youth (MIGHTY-fiber) | diabetes mellitus | Metformin (NPC230775) | NP level |
| NCT01334125 | Adjunctive Metformin Therapy in Double Diabetes | diabetes mellitus | Metformin (NPC230775) | NP level |
| NCT00859898 | Study of Dapagliflozin in Combination With Metformin XR to Initiate the Treatment of Type 2 Diabetes | type 2 diabetes mellitus | Metformin (NPC230775) | NP level |
| NCT02773927 | Combination of Metformin/Inulin vs Inulin on Adiponectin in Metabolic Syndrome | metabolic syndrome | Metformin (NPC230775) | NP level |
| NCT02895750 | Efficacity and Safety of Metformin XR in CKD Stage 1 to 3 | chronic kidney disease | Metformin (NPC230775) | NP level |
| NCT03889795 | Phase IB Metformin, Digoxin, Simvastatin in Solid Tumors | pancreatic carcinoma | Metformin (NPC230775) | NP level |
| NCT00754403 | Efficacy of Pioglitazone and Fortamet Combination Therapy in Subjects With Type 2 Diabetes | diabetes mellitus | Metformin (NPC230775) | NP level |
| NCT02372656 | Simvastatin and Metformin in Chronic Periodontitis | periodontitis | Metformin (NPC230775) | NP level |
| NCT01885013 | Myocet + Cyclophosphamide + Metformin Vs Myocet + Cyclophosphamide in 1st Line Treatment of HER2 Neg. Metastatic Breast Cancer Patients | breast carcinoma | Metformin (NPC230775) | NP level |
| NCT00414245 | Metformin for the Treatment of Diabetes in Pregnancy | gestational diabetes;type 2 diabetes mellitus | Metformin (NPC230775) | NP level |
| NCT01864096 | The Metformin Active Surveillance Trial (MAST) Study | prostate cancer | Metformin (NPC230775) | NP level |
| NCT00333151 | Effect of Liraglutide on Blood Glucose Control in Subjects With Type 2 Diabetes | type 2 diabetes mellitus | Metformin (NPC230775) | NP level |
| NCT03072485 | Phase 1 Study of the Effects of Combining Topical FDA-approved Drugs on Age-related Pathways on the Skin of Healthy Volunteers | aging | Metformin (NPC230775) | NP level |
| NCT00948402 | PED/PEA-15 Protein, PCOS, Obesity, Insulin Sensitivity Indexes, Metformin, Oral Contraceptives | polycystic ovary syndrome | Metformin (NPC230775) | NP level |
| NCT00359112 | AVANDAMET Versus Metformin And Sulphonylurea In People With Poorly Controlled Type 2 Diabetes | type 2 diabetes mellitus | Metformin (NPC230775) | NP level |
| NCT01488552 | Gemcitabine+Nab-paclitaxel and FOLFIRINOX and Molecular Profiling for Patients With Advanced Pancreatic Cancer | pancreatic carcinoma | Metformin (NPC230775) | NP level |
| NCT00930579 | Pre-Surgical Study: Effect of Metformin on Breast Cancer Proliferation | breast cancer | Metformin (NPC230775) | NP level |
| NCT01068743 | Bioequivalence Study of Fixed Dose Combination of 2.5 mg Saxagliptin/850 mg Metformin Tablet Relative to 2.5 mg Onglyza and 850 mg Glucophage Tablets Co-Administered | type 2 diabetes mellitus | Metformin (NPC230775) | NP level |
| NCT00892073 | Hypothalamic Obesity Following Craniopharyngioma Surgery: A Pilot Trial of Combined Metformin and Diazoxide Therapy | obesity | Metformin (NPC230775) | NP level |
| NCT01126580 | A Study in Participants With Type 2 Diabetes Mellitus (AWARD-3) | type 2 diabetes mellitus | Metformin (NPC230775) | NP level |
| NCT03047837 | A Randomized, 2x2 Factorial Design Biomarker Prevention Trial of Low-dose Aspirin and Metformin in Stage I-III Colorectal Cancer Patients. | malignant colon neoplasm | Metformin (NPC230775) | NP level |
| NCT01717482 | Metformin as a Chemoprevention Agent in Non-small Cell Lung Cancer | non-small cell lung carcinoma | Metformin (NPC230775) | NP level |
| NCT00754988 | A Study of Taspoglutide Versus Sitagliptin for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin. | type 2 diabetes mellitus | Metformin (NPC230775) | NP level |
| NCT04939935 | Implementation of Metformin theraPy to Ease Decline of Kidney Function in Polycystic Kidney Disease (IMPEDE-PKD) | Autosomal dominant polycystic kidney disease | Metformin (NPC230775) | NP level |
| NCT02593097 | Metformin for the Prevention of Episodic Migraine (MPEM) | migraine disorder | Metformin (NPC230775) | NP level |
| NCT00767000 | Dose Range Finding Study of MK-0941 in Patients With Type 2 Diabetes Mellitus on Insulin (MK-0941-007 AM3 EXT1 AM1)(TERMINATED) | type 2 diabetes mellitus | Metformin (NPC230775) | NP level |
| NCT05053841 | Implication of Metformin Plus Aromatase Inhibitor in Obese Postmenopausal Breast Cancer Women | breast cancer | Metformin (NPC230775) | NP level |
| NCT01266486 | Effect of Metformin on Breast Cancer Metabolism | breast cancer | Metformin (NPC230775) | NP level |
| NCT01981525 | A Pilot Study of Metformin in Patients With a Diagnosis of Li-Fraumeni Syndrome | Li-Fraumeni syndrome | Metformin (NPC230775) | NP level |
| NCT02437656 | Combination of Metformin to Neoadjuvant Radiochemotherapy in the Treatment of Locally Advanced Rectal Cancer (METCAP). | rectum cancer | Metformin (NPC230775) | NP level |
| NCT01589367 | Neoadjuvant Letrozole Plus Metformin vs Letrozole Plus Placebo for ER-positive Postmenopausal Breast Cancer | breast cancer | Metformin (NPC230775) | NP level |
| NCT01383356 | Comparison of the Bioavailability of Metformin Between Medium Dose Linagliptin/Metformin Tablets and Medium Dose Glucophage Tablet Given With Linagliptin Tablet | type 2 diabetes mellitus | Metformin (NPC230775) | NP level |
| NCT01434186 | A Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Saxagliptin (BMS-477118) in Combination With Metformin IR or Metformin XR in Pediatric Patients With Type 2 Diabetes Who Have Inadequate Glycemic Control on Metformin Alone | type 2 diabetes mellitus | Metformin (NPC230775) | NP level |
| NCT03179254 | Type 2 Diabetes and Ambulatory Surgery Patients | diabetes mellitus | Metformin (NPC230775) | NP level |
| NCT01089205 | Bioequivalence Study of Metformin Hydrochloride Extended Release 750 mg Tablets Versus Glucophage XR® 750 mg Tablet in Healthy Volunteers Under Fed Conditions. | type 2 diabetes mellitus | Metformin (NPC230775) | NP level |
| NCT00881725 | A Study of Pre-operative Metformin in Prostate Cancer | prostate cancer | Metformin (NPC230775) | NP level |
| NCT00617058 | Improving Metabolic Parameters of Antipsychotic Child Treatment With Ziprasidone, Aripiprazole, and Clozapine | body weight gain | Metformin (NPC230775) | NP level |
| NCT03000218 | Evaluation of PK and Biomarkers After UDCA Administrations to Subjects Who Are Overweight and Have Liver Problems | Elevated hepatic transaminase;obesity | Metformin (NPC230775) | NP level |
| NCT00838903 | Efficacy and Safety of Albiglutide in Treatment of Type 2 Diabetes | type 2 diabetes mellitus | Metformin (NPC230775) | NP level |
| NCT00763815 | GLP-1 Receptor Agonist Lixisenatide in Patients With Type 2 Diabetes for Glycemic Control and Safety Evaluation, on Top of Pioglitazone | type 2 diabetes mellitus | Metformin (NPC230775) | NP level |
| NCT00961857 | A Study to Demonstrate the Bioequivalence of Sitagliptin/Metformin Combination Tablets and Concomitant Administration of Sitagliptin and Metformin as Individual Tablets (0431A-048) | type 2 diabetes mellitus | Metformin (NPC230775) | NP level |
| NCT00348712 | Efficacy and Safety of Inhaled Pre-prandial Human Insulin in Type 2 Diabetes | type 2 diabetes mellitus | Metformin (NPC230775) | NP level |
| NCT05305898 | "MetCool ACS"- Metformin "Cooling" Effect on Metformin-naive Patients Treated With PCI Because of Acute Coronary Syndrome | acute coronary syndrome | Metformin (NPC230775) | NP level |
| NCT00701090 | A Study to Test the Safety and Efficacy of Sitagliptin Compared to Glimepiride in Patients With Type 2 Diabetes on a Stable Dose of Metformin (0431-803)(COMPLETED) | type 2 diabetes mellitus | Metformin (NPC230775) | NP level |
| NCT01192152 | Bioequivalence Study of the Fixed Dose Combination of 5 mg Saxagliptin/1000 mg Metformin XR (Manufactured in Mt Vernon, IN) Relative to 5 mg of Onglyza and 2 × 500 mg Glucophage XR | diabetes mellitus | Metformin (NPC230775) | NP level |
| NCT03861767 | REMAP Trial for Optimizing Surgical Outcomes at UPMC | aging | Metformin (NPC230775) | NP level |
| NCT02682121 | Mitochondrial-related Platelet Transcript Expression Levels in Pre-diabetic Subjects Randomized to Metformin or Placebo | prediabetes syndrome | Metformin (NPC230775) | NP level |
| NCT00303537 | Metformin in Non-Alcoholic Fatty Liver Disease | Hepatic steatosis | Metformin (NPC230775) | NP level |
| NCT00174642 | Opposing Step-by-step Insulin Reinforcement to Intensified Strategy | type 2 diabetes mellitus | Metformin (NPC230775) | NP level |
| NCT03905941 | Relative Desirability of Metformin vs. Birth Control Pill in Treating PCOS in Women of Later Reproductive Age | polycystic ovary syndrome | Metformin (NPC230775) | NP level |
| NCT03151772 | Bioavailability of Disulfiram and Metformin in Glioblastomas | glioblastoma multiforme | Metformin (NPC230775) | NP level |
| NCT00328172 | Efficacy and Safety of 3 Doses of BI1356 (Linagliptin) in Type 2 Diabetes Patients | type 2 diabetes mellitus | Metformin (NPC230775) | NP level |
| NCT00755287 | A Study of the Safety, Tolerability and Effect on Glycemic Control of Taspoglutide Versus Insulin Glargine in Insulin Naive Type 2 Diabetic Patients Inadequately Controlled With Metformin Plus Sulphonylurea. | type 2 diabetes mellitus | Metformin (NPC230775) | NP level |
| NCT02048761 | Locally Delivered 1% Metformin Gel in the Treatment of Intrabony Defects in Chronic Periodontitis | periodontitis | Metformin (NPC230775) | NP level |
| NCT01169779 | Efficacy and Safety of Lixisenatide in Patients With Type 2 Diabetes Mellitus Insufficiently Controlled by Metformin | type 2 diabetes mellitus | Metformin (NPC230775) | NP level |
| NCT01028391 | 30-Week Extension to an Initial Combination Study (24 Weeks in Duration) of Sitagliptin With Pioglitazone (0431-064) | type 2 diabetes mellitus | Metformin (NPC230775) | NP level |
| NCT00349635 | A Controlled-Study on the Effect of a Combination of Fenofibrate and Metformin on Weight Loss and Weight Loss-Maintenance, in Obese Patients. | obesity | Metformin (NPC230775) | NP level |
| NCT03379909 | Phase II Study of Oral Metformin for Intravesical Treatment of Non-muscle-invasive Bladder Cancer | urinary bladder cancer | Metformin (NPC230775) | NP level |
| NCT00159536 | Metformin in Pregnant PCOS Women | polycystic ovary syndrome | Metformin (NPC230775) | NP level |
| NCT01240759 | Safety and Efficacy of S-707106 in Subjects With Type 2 Diabetes Mellitus and Inadequate Glycemic Control With Metformin Therapy | type 2 diabetes mellitus | Metformin (NPC230775) | NP level |
| NCT00000620 | Action to Control Cardiovascular Risk in Diabetes (ACCORD) | atherosclerosis;coronary artery disease;Hypercholesterolemia;hypertension;type 2 diabetes mellitus | Metformin (NPC230775) | NP level |
| NCT01911247 | Preoperative Window Study of Metformin for the Treatment of Endometrial Cancer | endometrial cancer | Metformin (NPC230775) | NP level |
| NCT00614120 | Effect of Liraglutide or Glimepiride Added to Metformin on Blood Glucose Control in Subjects With Type 2 Diabetes | type 2 diabetes mellitus | Metformin (NPC230775) | NP level |
| NCT02719756 | Effect of SGLT-2 Inhibitor Dapagliflozin on Glycemic Variability in Patients With Diabetes Mellitus Type 2 | diabetes mellitus | Metformin (NPC230775) | NP level |
| NCT02484209 | DiaFrail: A Short Duration Study in Older People ( DIAFRAIL Study) | diabetes mellitus | Metformin (NPC230775) | NP level |
| NCT00466622 | Uterine Artery Blood Flow in Pregnant Women With PCOS Treated With Metformin | polycystic ovary syndrome | Metformin (NPC230775) | NP level |
| NCT04224051 | Metformin for Abdominal Aortic Aneurysm Growth Inhibition | Abdominal Aortic Aneurysm | Metformin (NPC230775) | NP level |
| NCT00703755 | A Randomized, Double-Blind Trial Comparing the Efficacy and Safety of Fenofibrate, Metformin, Their Combination and Placebo in Patients With Metabolic Syndrome. | metabolic syndrome | Metformin (NPC230775) | NP level |
| NCT04055012 | Effects of Metformin on Low Back Pain | Low back pain | Metformin (NPC230775) | NP level |
| NCT03670043 | Tolerance & Responsiveness Improvement for Metformin (TRIM) | diabetes mellitus | Metformin (NPC230775) | NP level |
| NCT00783744 | Insulin Glargine Combination Therapies in Type II Diabetics | type 2 diabetes mellitus | Metformin (NPC230775) | NP level |
| NCT02294006 | Activity and Safety of Everolimus+Octreotide LAR+Metformin in Advanced Pancreatic Well-differentiated NETs | pancreatic neuroendocrine tumor | Metformin (NPC230775) | NP level |
| NCT04121468 | A Phase I Double Blind Study of Metformin Acting on Endogenous Neural Progenitor Cells in Children With Multiple Sclerosis | multiple sclerosis | Metformin (NPC230775) | NP level |
| NCT03713801 | Impact of Metformin on Immunity | aging | Metformin (NPC230775) | NP level |
| NCT00279240 | Life Style Modifications Prevents Type 2 Diabetes in Asian Indians | diabetes mellitus | Metformin (NPC230775) | NP level |
| NCT02810132 | Effects of Metformin Treatment on Myocardial Efficiency in Patients With Heart Failure | systolic heart failure | Metformin (NPC230775) | NP level |
| NCT00814372 | Evaluate Safety and Effectiveness of MBX-102 in Type 2 Diabetes Patients With Poor Glycemic Control on Metformin | type 2 diabetes mellitus | Metformin (NPC230775) | NP level |
| NCT00420511 | Beta-Cell Function and Sitagliptin Trial (BEST) | type 2 diabetes mellitus | Metformin (NPC230775) | NP level |
❱❱❱ Associated Human Diseases and Detailed Association Evidence
How do we define the Plant-Targeted Human Disease Association?
Associated human diseases of an individual plant are summurized based on FOUR types of association evidence, these include:
❶ Association by Therapeutic Target: Bioactive protein targets of the plant were defined in "Molecular Targets" section, target-disease associations collected from TTD database were subsequently used to build the associations between the plant and its targeted human diseases.
❷ Association by Disease Gene Reversion: Plant and a specific disease will be associated when >= 1 plant target gene overlaped with disease's DEGs.
❸ Association by Clinical Trials of Plant: Plant and a specific disease will be associated when >= 1 clinical trial (the plant is the intervetion) can be matched in ClinicalTrials.gov database.
❹ Association by Clinical Trials of Plant Ingredients: Plant and a specific disease will be associated when >= 1 clinical trial (the plant ingredient is the intervetion) can be matched in ClinicalTrials.gov database.
Associated Disease of the Plant |
Association Type & Detailed Evidence |
|---|---|
Diabetes mellitus arising in pregnancyDisease Category: 18.Pregnancy, childbirth or the puerperiumDisease ICD-11 Code: JA63.2 |
NCT03651531,NCT01215331,NCT03841591,NCT02275845,NCT04615351,NCT03320694,NCT01329016,NCT00414245,NCT01087866
|
Periodontal diseaseDisease Category: 13.Diseases of the digestive systemDisease ICD-11 Code: DA0C |
NCT02580331,NCT02048761,NCT02274090,NCT02461667,NCT02283554,NCT02372656,NCT03204058,NCT03204071
|
Rheumatoid arthritisDisease Category: 15.Diseases of the musculoskeletal system or connective tissueDisease ICD-11 Code: FA20 |
PDE4D,NFKB1,PTGS1
NCT04196868,NCT03863405,NCT04068246,NCT01405118 |
Endometrial cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C76 |
NCT01911247,NCT04792749,NCT02042495,NCT01797523,NCT01205672,NCT02755844,NCT02990728
|
Intermediate hyperglycaemia, unspecifiedDisease Category: 05.Endocrine, nutritional or metabolic diseasesDisease ICD-11 Code: 5A40.Z |
NCT01804049,NCT01336322,NCT02682121,NCT04742751,NCT03848533,NCT01779362,NCT01779375
|
Non-small cell lung cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C25 |
NCT02019979,NCT03086733,NCT01864681,NCT01997775,NCT04170959,NCT01717482
|
Glioblastoma, primary, NOSDisease Category: X.Extension CodesDisease ICD-11 Code: XH0MB1 |
NCT02780024,NCT04691960,NCT03151772,NCT03243851,NCT04945148,NCT05183204
|
Diabetes mellitus, type unspecifiedDisease Category: 05.Endocrine, nutritional or metabolic diseasesDisease ICD-11 Code: 5A14 |
NFKB1
NCT00770835,NCT00316082,NCT01613755,NCT04050098,NCT00038727,NCT00772174,NCT03039075,NCT03824002,NCT01766778,NCT03258723,NCT04998032,NCT01814748,NCT01915550,NCT01464437,NCT00286442,NCT02719756,NCT00684528,NCT03030300,NCT00683735,NCT05262257,NCT00727857,NCT01192152,NCT05440591,NCT00046462,NCT02844803,NCT00754403,NCT00820573,NCT01107717,NCT01874080,NCT01192139,NCT04581447,NCT00969566,NCT00279240,NCT00313313,NCT04209075,NCT00762957,NCT02088034,NCT01370707,NCT04416269,NCT01334125,NCT00108615,NCT02484209,NCT03670043,NCT03179254,NCT02956044,NCT00959101,NCT02042664,NCT00432276,NCT01890122,NCT00770445,NCT02249910,NCT00327015,NCT01046422 |
Type1diabetesmellitusDisease Category: 05.Endocrine, nutritional or metabolic diseasesDisease ICD-11 Code: 5A10 |
NCT01483560,NCT04177303,NCT01881828,NCT02045290,NCT01808690
|
Squamous cell carcinomaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B60-2D01 |
NCT03833466,NCT03076281,NCT03618654,NCT02394652,NCT02083692
|
Non-alcoholic fatty liver diseaseDisease Category: 13.Diseases of the digestive systemDisease ICD-11 Code: DB92 |
NCT04972396,NCT01084486,NCT00699036,NCT02457286,NCT02696941
|
Ageing associated decline in intrinsic capacityDisease Category: 21.Symptoms, signs or clinical findings, not elsewhere classifiedDisease ICD-11 Code: MG2A |
NCT03861767,NCT03713801,NCT02308228,NCT03072485,NCT04264897
|
Muscular dystrophyDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8C70 |
NFKB1,PTGS1
NCT01995032,NCT02018731 |
Multiple sclerosisDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8A40 |
NFKB1
NCT05131828,NCT05298670,NCT04121468 |
Colorectal cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B91 |
PTGS1
NCT02614339,NCT01816659,NCT01632020 |
Fragile X chromosomeDisease Category: 20.Developmental anomaliesDisease ICD-11 Code: LD55 |
NCT03862950,NCT03722290,NCT04141163,NCT03479476
|
MelanomaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C30 |
NCT02190838,NCT03311308,NCT02143050,NCT01638676
|
Diffuse large B-cell lymphomaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A81 |
NCT03600363,NCT02531308,NCT02815397,NCT03200015
|
Malignant neoplasm of pancreas, unspecifiedDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C10.Z |
NCT03889795,NCT01488552,NCT01167738,NCT01210911
|
Pulmonary hypertensionDisease Category: 11.Diseases of the circulatory systemDisease ICD-11 Code: BB01 |
NCT01352026,NCT01880866,NCT00000620,NCT03617458
|
Autosomal dominant polycystic kidney diseaseDisease Category: 16.Diseases of the genitourinary systemDisease ICD-11 Code: GB81 |
NCT02656017,NCT04939935,NCT03764605,NCT02903511
|
Neuroendocrine carcinomaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C34 |
NCT02823691,NCT02254512,NCT02279758,NCT02294006
|
Carcinosarcoma of uterusDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C76.43 |
HSD17B10,ALPL,NUDT1,PTGS1
|
Malignant neoplasms of biliary tract, distal bile ductDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C15 |
ALOX12,LMNA,NUDT1,PTGS1
|
Adenocarcinoma of pancreasDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C10.0 |
PDE4D,SNCA,LMNA,PTGS1
|
Germ cell tumour of testisDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C80.2 |
SNCA,ALOX12,NUDT1,PTGS1
|
Polycystic ovary syndromeDisease Category: 05.Endocrine, nutritional or metabolic diseasesDisease ICD-11 Code: 5A80.1 |
NCT00948402,NCT01775176,NCT00283816,NCT04113889,NCT02026869,NCT03674385,NCT03008551,NCT03905941,NCT04973891,NCT03117517,NCT02086526,NCT03108963,NCT02562664,NCT00714233,NCT01733459,NCT05394142,NCT02022007,NCT00466622,NCT03086005,NCT04852510,NCT00344851,NCT04867252,NCT01482286,NCT01622257,NCT03981861,NCT02689843,NCT03229057,NCT01581814,NCT02498522,NCT00151411,NCT03259919,NCT02244567,NCT00159536
|
Atopic eczemaDisease Category: 14.Diseases of the skinDisease ICD-11 Code: EA80 |
PTGS1,NFKB1,PDE4D
|
ParkinsonismDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8A00 |
SNCA,PTGS1,PDE4D
|
Alzheimer diseaseDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8A20 |
SNCA,PDE4D,PTGS1
|
PsoriasisDisease Category: 14.Diseases of the skinDisease ICD-11 Code: EA90 |
NFKB1,PDE4D
NCT02644954 |
Chronic kidney diseaseDisease Category: 16.Diseases of the genitourinary systemDisease ICD-11 Code: GB61 |
NCT02848508,NCT02895750,NCT05373680
|
NeoplasmsDisease Category: 02.NeoplasmsDisease ICD-11 Code: 02 |
NCT01566799,NCT04428086,NCT03017833
|
Male infertilityDisease Category: 16.Diseases of the genitourinary systemDisease ICD-11 Code: GB04 |
NCT03681197,NCT02848950,NCT03135301
|
Rectum cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B92 |
NCT03053544,NCT02473094,NCT02437656
|
Malignant neoplasm metastasis in male genital organsDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2E06 |
NCT04926155,NCT04925063,NCT01677897
|
Unspecified malignant neoplasms of unspecified sitesDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2D4Z |
NCT01529593,NCT01087983,NCT01442870
|
Primary neoplasms of brainDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A00 |
NCT02040376,NCT01528046,NCT02149459
|
AdenocarcinomaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2D40 |
NCT02186847,NCT01578551,NCT01877564
|
Malignant neoplasms of prostate, unspecifiedDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C82.Z |
NCT02640534,NCT01561482,NCT02614859
|
Serous cystadenoma,borderline malignancy of ovaryDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C73.4 |
ALPL,ALOX12,NUDT1
|
PheochromocytomaDisease Category: X.Extension CodesDisease ICD-11 Code: XH3854 |
PDE4D,SNCA,PTGS1
|
Diffuse large B-cell lymphomasDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A81 |
LMNA,NUDT1,HSD17B10
|
Mesothelioma of pleuraDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C26.0 |
SNCA,LMNA,PTGS1
|
Malignant neoplasms of adrenal glandDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2D11 |
PDE4D,SNCA,NUDT1
|
Breast cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C60-2C6Y |
NCT01266486,NCT02028221,NCT00930579,NCT01589367,NCT03238495,NCT02360059,NCT04143282,NCT03006172,NCT02506790,NCT04559308,NCT04300790,NCT01627067,NCT01980823,NCT01477060,NCT02488564,NCT04248998,NCT02506777,NCT00909506,NCT01302002,NCT03192293,NCT01042379,NCT01650506,NCT02472353,NCT04899349,NCT01310231,NCT05053841
|
Type 2 diabetes mellitusDisease Category: 05.Endocrine, nutritional or metabolic diseasesDisease ICD-11 Code: 5A11 |
NFKB1,PTGS1
NCT00376038,NCT01204775,NCT00110851,NCT00528879,NCT00499707,NCT00885378,NCT00763451,NCT00611884,NCT00266253,NCT00543361,NCT00961909,NCT00961857,NCT00792935,NCT01126580,NCT01434186,NCT01289119,NCT00722371,NCT00131664,NCT00924573,NCT00396357,NCT00915772,NCT01034111,NCT00885352,NCT00673465,NCT01089192,NCT01068730,NCT01095653,NCT01353391,NCT00838903,NCT00712673,NCT00571519,NCT00337610,NCT01217073,NCT00900146,NCT00856986,NCT00000620,NCT00901979,NCT00086515,NCT00479466,NCT00715624,NCT01135433,NCT00975052,NCT00481663,NCT00789035,NCT00690456,NCT00627445,NCT00350779,NCT01076088,NCT00631488,NCT00261352,NCT00103857,NCT00174642,NCT01106677,NCT00332488,NCT00755287,NCT00318461,NCT01023581,NCT01093794,NCT00333151,NCT00121667,NCT01381900,NCT01089179,NCT00767000,NCT00856284,NCT01292993,NCT01106625,NCT00860288,NCT00414245,NCT01383356,NCT00263276,NCT01340664,NCT00427154,NCT01075282,NCT00868790,NCT01169779,NCT00643851,NCT00744367,NCT00672386,NCT00734474,NCT01068717,NCT00541775,NCT01318109,NCT00528372,NCT01117584,NCT00081328,NCT00851903,NCT00707031,NCT01175473,NCT00575588,NCT00698230,NCT01240759,NCT00918138,NCT00067951,NCT00875394,NCT01396564,NCT01217892,NCT00743002,NCT01245166,NCT00375388,NCT01302145,NCT01296412,NCT00976937,NCT01071850,NCT00328172,NCT00814372,NCT00763815,NCT00968812,NCT01137812,NCT00032487,NCT00263965,NCT00454233,NCT00839527,NCT01051011,NCT01211197,NCT01332071,NCT00383578,NCT00106340,NCT00086502,NCT01028391,NCT00379769,NCT00097279,NCT01095666,NCT00399711,NCT00272064,NCT00899470,NCT01357876,NCT00449605,NCT00316758,NCT00121641,NCT00295633,NCT01002807,NCT00713830,NCT00087516,NCT00420511,NCT00961480,NCT01089205,NCT00359112,NCT00881530,NCT00519480,NCT00783744,NCT00754689,NCT00975286,NCT00279045,NCT01204294,NCT00598793,NCT00859898,NCT01076075,NCT00700817,NCT00960661,NCT01318135,NCT00960076,NCT00184574,NCT00331851,NCT00374907,NCT00353691,NCT00097500,NCT00614120,NCT01462266,NCT01068743,NCT01089166,NCT00613951,NCT00482729,NCT00971243,NCT01459809,NCT00728351,NCT00701090,NCT01340768,NCT00099866,NCT00614055,NCT00855166,NCT00111631,NCT01305551,NCT00971659,NCT00830076,NCT01368081,NCT01365091,NCT00605475,NCT00798161,NCT00698789,NCT01059825,NCT00469586,NCT00661362,NCT00871936,NCT00382096,NCT00468039,NCT00425009,NCT01106690,NCT01154348,NCT00102466,NCT00348712,NCT01111955,NCT00789191,NCT01064687,NCT01472367,NCT00676338,NCT00525330,NCT00069836,NCT00544518,NCT00754988,NCT00251953 |
OsteoarthritisDisease Category: 15.Diseases of the musculoskeletal system or connective tissueDisease ICD-11 Code: FA00-FA05 |
PTGS1
NCT04767841 |
Choreiform disorderDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8A01 |
NFKB1,PDE4D
|
Indeterminate colitisDisease Category: 13.Diseases of the digestive systemDisease ICD-11 Code: DD72 |
NFKB1,PTGS1
|
HIV-infected patients with tuberculosisDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1B10-1B14 |
PTGS1
NCT05215990 |
Solid tumour/cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A00-2F9Z |
NFKB1,PTGS1
|
Chronic obstructive pulmonary diseaseDisease Category: 12.Diseases of the respiratory systemDisease ICD-11 Code: CA22 |
PDE4D
NCT03651895 |
Crohn diseaseDisease Category: 13.Diseases of the digestive systemDisease ICD-11 Code: DD70 |
PDE4D
ALPL |
Cardiovascular diseaseDisease Category: 11.Diseases of the circulatory systemDisease ICD-11 Code: BA00-BE2Z |
PTGS1
NCT01037660 |
Ulcerative colitisDisease Category: 13.Diseases of the digestive systemDisease ICD-11 Code: DD71 |
PTGS1
NCT04750135 |
Breast in situ carcinomaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2E65 |
NCT01885013,NCT02278965
|
Heart failureDisease Category: 11.Diseases of the circulatory systemDisease ICD-11 Code: BD10-BD1Z |
NCT02810132,NCT05093959
|
Endometrial glandular hyperplasiaDisease Category: 16.Diseases of the genitourinary systemDisease ICD-11 Code: GA16.0 |
NCT04607252,NCT01685762
|
Insulin-resistance syndromesDisease Category: 05.Endocrine, nutritional or metabolic diseasesDisease ICD-11 Code: 5A44 |
NCT04148183,NCT04264897
|
COVID-19Disease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1D6Y |
NCT04510194,NCT04604678
|
Becker muscular dystrophyDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8C70.0 |
NCT03236662,NCT01856868
|
Malignant neoplasms of bladder, unspecifiedDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C94.Z |
NCT02360618,NCT03379909
|
Aneurysm/dissectionDisease Category: 11.Diseases of the circulatory systemDisease ICD-11 Code: BD50 |
NCT04224051,NCT04500756
|
Ovarian cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C73 |
NCT02312661,NCT03378297
|
Other specified malignant neoplasms of colonDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B90.Y |
NCT01926769,NCT01725490
|
Symptoms and signs involving cognition, unspecifiedDisease Category: 21.Symptoms, signs or clinical findings, not elsewhere classifiedDisease ICD-11 Code: MB21.Z |
NCT04098666,NCT00620191
|
Head and neck cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2D42 |
NCT02402348,NCT02325401
|
Disorders of intellectual development, unspecifiedDisease Category: 06.Mental, behavioural or neurodevelopmental disordersDisease ICD-11 Code: 6A00.Z |
NCT03862950,NCT03479476
|
Acute viral hepatitisDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1E50 |
NCT00063232,NCT03000218
|
Hepatocellular carcinoma, NOSDisease Category: X.Extension CodesDisease ICD-11 Code: XH4W48 |
NCT02672488,NCT02819869
|
Adenocarcinoma of prostateDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C82.0 |
NCT01996696,NCT01796028
|
Other specified non-alcoholic fatty liver diseaseDisease Category: 13.Diseases of the digestive systemDisease ICD-11 Code: DB92.Y |
NCT00303537,NCT00063635
|
Sex development malformative disorderDisease Category: 20.Developmental anomaliesDisease ICD-11 Code: LD2A |
NCT03479476,NCT03862950
|
Lung cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C25 |
NCT02115464,NCT02285855
|
Malignant neoplasm metastasis in lymph nodes of head, face or neckDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2D60.0 |
NCT02949700,NCT04414540
|
SchizophreniaDisease Category: 06.Mental, behavioural or neurodevelopmental disordersDisease ICD-11 Code: 6A20 |
NCT00401973,NCT04865835
|
Human immunodeficiency virus disease without mention of associated disease or condition, clinical stage unspecifiedDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1C62.Z |
NCT02659306,NCT02064374
|
Malignant neoplasms of colonDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B90 |
NCT01440127,NCT03047837
|
Neurobehavioral disorderDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8A00-8A0Z |
NCT03479476,NCT03862950
|
Squamous cell carcinoma of bronchus or lungDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C25.2 |
ALOX12,NUDT1
|
Superficial ovarian endometriosisDisease Category: 16.Diseases of the genitourinary systemDisease ICD-11 Code: GA10.B4 |
SNCA,LMNA
|
Malignant neoplasms of thymusDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C27 |
NFKB1,HSD17B10
|
Glioblastoma of brainDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A00.00 |
LMNA,PTGS1
|
Prostate cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C82 |
NCT03465345,NCT00268476,NCT01864096,NCT01243385,NCT03137186,NCT01215032,NCT01733836,NCT02497638,NCT02946996,NCT01620593,NCT00881725,NCT04536805,NCT02945813
|
ObesityDisease Category: 05.Endocrine, nutritional or metabolic diseasesDisease ICD-11 Code: 5B80-5B81 |
NCT00349635,NCT00892073,NCT00842400,NCT03349775,NCT01725126,NCT00631033,NCT04839237,NCT02063802,NCT00120146,NCT03000218,NCT01677923,NCT00941382
|
Metabolic disorderDisease Category: 05.Endocrine, nutritional or metabolic diseasesDisease ICD-11 Code: 5C50-5D2Z |
NCT00349128,NCT02773927,NCT02778776,NCT00348725,NCT00703755,NCT04817787,NCT01046500,NCT00362323,NCT01234649,NCT02629627
|
Inherited coagulation factor deficiencyDisease Category: 03.Diseases of the blood or blood-forming organsDisease ICD-11 Code: 3B14 |
PTGS1
|
Irritable bowel syndromeDisease Category: 13.Diseases of the digestive systemDisease ICD-11 Code: DD91 |
NFKB1
|
Inflammatory spondyloarthritisDisease Category: 15.Diseases of the musculoskeletal system or connective tissueDisease ICD-11 Code: FA92 |
PTGS1
|
Urinary system diseaseDisease Category: 16.Diseases of the genitourinary systemDisease ICD-11 Code: GC2Z |
PTGS1
|
Mild neurocognitive disorderDisease Category: 06.Mental, behavioural or neurodevelopmental disordersDisease ICD-11 Code: 6D71 |
PDE4D
|
Pain, unspecifiedDisease Category: 21.Symptoms, signs or clinical findings, not elsewhere classifiedDisease ICD-11 Code: MG3Z |
PTGS1
|
Ataxic disorderDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8A03 |
PTGS1
|
Tonus and reflex abnormalityDisease Category: 21.Symptoms, signs or clinical findings, not elsewhere classifiedDisease ICD-11 Code: MB47 |
PDE4D
|
Nutritional deficiencyDisease Category: 05.Endocrine, nutritional or metabolic diseasesDisease ICD-11 Code: 5B50-5B71 |
PTGS1
|
Reactive arthropathyDisease Category: 15.Diseases of the musculoskeletal system or connective tissueDisease ICD-11 Code: FA11 |
PTGS1
|
Systemic sclerosisDisease Category: 04.Diseases of the immune systemDisease ICD-11 Code: 4A42 |
PTGS1
|
Genetic prion diseaseDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8E02 |
ALPL
|
Female pelvic painDisease Category: 16.Diseases of the genitourinary systemDisease ICD-11 Code: GA34 |
PTGS1
|
VasculitisDisease Category: 04.Diseases of the immune systemDisease ICD-11 Code: 4A44 |
PTGS1
|
Hyper-lipoproteinaemiaDisease Category: 05.Endocrine, nutritional or metabolic diseasesDisease ICD-11 Code: 5C80 |
PTGS1
|
Lupus erythematosusDisease Category: 04.Diseases of the immune systemDisease ICD-11 Code: 4A40 |
NFKB1
|
Cerebral ischaemiaDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8B1Z |
PTGS1
|
Otitis mediaDisease Category: 10.Diseases of the ear or mastoid processDisease ICD-11 Code: AA80-AB0Z |
PTGS1
|
Autonomic nervous system disorderDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8D87 |
SNCA
|
Parasitic infectionDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1D0Y-1G2Z |
ALPL
|
MigraineDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8A80 |
PTGS1
|
Eye anterior segment structural developmental anomalyDisease Category: 20.Developmental anomaliesDisease ICD-11 Code: LA11 |
PTGS1
|
AsthmaDisease Category: 12.Diseases of the respiratory systemDisease ICD-11 Code: CA23 |
PDE4D
|
Fungal infectionDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1F29-1F2F |
NFKB1
|
Mood disorderDisease Category: 06.Mental, behavioural or neurodevelopmental disordersDisease ICD-11 Code: 6A60-6E23 |
PDE4D
|
Skin and skin-structure infectionDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1F28-1G0Z |
NFKB1
|
Spinal painDisease Category: 21.Symptoms, signs or clinical findings, not elsewhere classifiedDisease ICD-11 Code: ME84 |
PTGS1
|
Joint painDisease Category: 21.Symptoms, signs or clinical findings, not elsewhere classifiedDisease ICD-11 Code: ME82 |
PTGS1
|
Colon cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B90 |
ALPL
|
Postoperative inflammationDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1A00-CA43 |
PTGS1
|
Acute myeloid leukaemiaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A60 |
NFKB1
|
Myocardial infarctionDisease Category: 11.Diseases of the circulatory systemDisease ICD-11 Code: BA41-BA43 |
PTGS1
|
Seborrhoeic dermatitisDisease Category: 14.Diseases of the skinDisease ICD-11 Code: EA81 |
PTGS1
|
Acute/subacute hepatic failureDisease Category: 13.Diseases of the digestive systemDisease ICD-11 Code: DB91 |
NFKB1
|
EndometriosisDisease Category: 16.Diseases of the genitourinary systemDisease ICD-11 Code: GA10 |
PTGS1
|
NeuropathyDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8C0Z |
PTGS1
|
Adenocarcinoma, endocervical typeDisease Category: X.Extension CodesDisease ICD-11 Code: XH0GS9 |
NCT02394652
|
Small cell carcinoma of bronchus or lungDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C25.1 |
NCT03994744
|
AngiosarcomaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B56 |
NCT01042379
|
Schizophrenia or other primary psychotic disorders, unspecifiedDisease Category: 06.Mental, behavioural or neurodevelopmental disordersDisease ICD-11 Code: 6A2Z |
NCT04511416
|
Secondary progressive multiple sclerosisDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8A40.2 |
NCT05349474
|
Bipolar disorderDisease Category: 06.Mental, behavioural or neurodevelopmental disordersDisease ICD-11 Code: 6A60 |
NCT02519543
|
Single episode depressive disorder, severe, without psychotic symptomsDisease Category: 06.Mental, behavioural or neurodevelopmental disordersDisease ICD-11 Code: 6A70.3 |
NCT04088448
|
coronary artery diseaseDisease Category: 11.Diseases of the circulatory systemDisease ICD-11 Code: BA8Y-BA8Z |
NCT00000620
|
Low back painDisease Category: 21.Symptoms, signs or clinical findings, not elsewhere classifiedDisease ICD-11 Code: ME84.2 |
NCT04055012
|
Coronary atherosclerosisDisease Category: 11.Diseases of the circulatory systemDisease ICD-11 Code: BA80 |
NCT00000620
|
BlindnessDisease Category: 09.Diseases of the visual systemDisease ICD-11 Code: 9D90.6 |
NCT03490019
|
Pregnancy/childbirth/puerperium maternal infectionDisease Category: 18.Pregnancy, childbirth or the puerperiumDisease ICD-11 Code: JB63 |
NCT03056274
|
Hidradenitis suppurativaDisease Category: 14.Diseases of the skinDisease ICD-11 Code: ED92 |
NCT04649502
|
Sickle-cell disorderDisease Category: 03.Diseases of the blood or blood-forming organsDisease ICD-11 Code: 3A51 |
NCT02981329
|
Urogenital cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C95-2C9Z |
NCT02365597
|
Polyneuropathy, unspecifiedDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8C0Z |
NCT04780854
|
Obstructive sleep apnoeaDisease Category: 07.Sleep-wake disordersDisease ICD-11 Code: 7A41 |
NCT04530747
|
HypopituitarismDisease Category: 05.Endocrine, nutritional or metabolic diseasesDisease ICD-11 Code: 5A61.0 |
NCT03490019
|
Precursor cell lymphoblastic leukaemia, NOSDisease Category: X.Extension CodesDisease ICD-11 Code: XH5J37 |
NCT01324180
|
Duchenne muscular dystrophyDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8C70.1 |
NCT02516085
|
Inborn lipid metabolism errorDisease Category: 05.Endocrine, nutritional or metabolic diseasesDisease ICD-11 Code: 5C52 |
NCT00361868
|
Primary progressive multiple sclerosisDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8A40.1 |
NCT05349474
|
Osteosarcoma of bone and articular cartilage of other specified sitesDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B51.Y |
NCT01981525
|
RetinopathyDisease Category: 09.Diseases of the visual systemDisease ICD-11 Code: 9B71 |
NCT02587741
|
Chronic lymphocytic leukaemia or small lymphocytic lymphomaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A82.0 |
NCT01750567
|
DementiaDisease Category: 06.Mental, behavioural or neurodevelopmental disordersDisease ICD-11 Code: 6D80-6D8Z |
NCT04220021
|
Neuropathic painDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8E43.0 |
NCT00971295
|
Spastic cerebral palsyDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8D20 |
NCT03710343
|
Severe acute respiratory syndromeDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1D65 |
NCT04510194
|
Cervical cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C77 |
NCT04275713
|
Carcinomas of ovaryDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C73.0 |
NCT02437812
|
Schizoaffective disorderDisease Category: 06.Mental, behavioural or neurodevelopmental disordersDisease ICD-11 Code: 6A21 |
NCT00401973
|
Multiple myelomaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A83 |
NCT02967276
|
Generalised anxiety disorderDisease Category: 06.Mental, behavioural or neurodevelopmental disordersDisease ICD-11 Code: 6B00 |
NCT00809536
|
Central diabetes insipidusDisease Category: 05.Endocrine, nutritional or metabolic diseasesDisease ICD-11 Code: 5A61.5 |
NCT02460354
|
Malignant neoplasms of ill-defined sitesDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2D42 |
NCT03477162
|
MalariaDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1F40-1F45 |
NCT05236530
|
Chronic arterial occlusive disease, unspecifiedDisease Category: 11.Diseases of the circulatory systemDisease ICD-11 Code: BD4Z |
NCT03054519
|
Liver cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C12 |
NCT03184493
|
Columnar metaplastic epithelium of the oesophagus, unspecifiedDisease Category: 13.Diseases of the digestive systemDisease ICD-11 Code: DA23.Z |
NCT01465113
|
Follicular lymphomaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A80 |
NCT03600363
|
GlaucomaDisease Category: 09.Diseases of the visual systemDisease ICD-11 Code: 9C61 |
NCT05426044
|
Lipoatrophy/lipodystrophyDisease Category: 14.Diseases of the skinDisease ICD-11 Code: EF01 |
NCT00362440
|
Huntington diseaseDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8A01.10 |
NCT04826692
|
Impaired glucose toleranceDisease Category: 05.Endocrine, nutritional or metabolic diseasesDisease ICD-11 Code: 5A40.1 |
NCT01234649
|
Diabetic foot ulcerDisease Category: 11.Diseases of the circulatory systemDisease ICD-11 Code: BD54 |
NCT01710527
|
Thyroid cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2D10 |
NCT05468554
|
Migraine disorder(TM1)Disease Category: 26.Supplementary Chapter Traditional Medicine Conditions - Module IDisease ICD-11 Code: SD10 |
NCT02593097
|
LeprosyDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1B20 |
NCT05243654
|
NADisease Category: NADisease ICD-11 Code: NA |
NCT05132439
|
Macular degenerationDisease Category: 09.Diseases of the visual systemDisease ICD-11 Code: 9B75 |
NCT02684578
|
Squamous cell carcinoma of oropharynxDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B6A.0 |
NCT03618654
|
Atrial fibrillationDisease Category: 11.Diseases of the circulatory systemDisease ICD-11 Code: BC81.3 |
NCT02931253
|
Large cell carcinoma of bronchus or lungDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C25.3 |
NCT02186847
|
HypercholesterolaemiaDisease Category: 05.Endocrine, nutritional or metabolic diseasesDisease ICD-11 Code: 5C80.0 |
NCT00000620
|
Burn and burn infectionDisease Category: 22.Injury, poisoning or certain other consequences of external causesDisease ICD-11 Code: ND90-NE2Z |
NCT04530058
|
Acute ischaemic heart disease, unspecifiedDisease Category: 11.Diseases of the circulatory systemDisease ICD-11 Code: BA4Z |
NCT05305898
|
Malignant neoplasm metastasis, unspecifiedDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2E2Z |
NCT01840007
|
Inflammatory bowel diseases, unspecifiedDisease Category: 13.Diseases of the digestive systemDisease ICD-11 Code: DD7Z |
ALPL
|
Osteoarthritis, unspecifiedDisease Category: 15.Diseases of the musculoskeletal system or connective tissueDisease ICD-11 Code: FA0Z |
ALPL
|
HepatoblastomaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C12.01 |
NUDT1
|
LeishmaniasisDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1F54 |
ALPL
|
Other specified malignant neoplasms of kidney, except renal pelvisDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C90.Y |
NUDT1
|
West Nile virus infectionDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1D46 |
NFKB1
|
Hepatocellular carcinoma of liverDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C12.02 |
NUDT1
|
Malignant neoplasms of oesophagusDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B70 |
NUDT1
|
Cytomegaloviral diseaseDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1D82 |
PDE4D
|
Malignant neoplasms of thyroid gland, unspecifiedDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2D10.Z |
ALPL
|
Malignant neoplasms of corpus uteri, unspecifiedDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C76.Z |
ALPL
|
Chikungunya virus diseaseDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1D40 |
LMNA
|
Carpal tunnel syndromeDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8C10.0 |
PDE4D
|
Gliomas of brainDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A00.0 |
PTGS1
|
❱❱❱ Network Visualization of Plant-Targeted Human Disease Associations
Plant-Targeted Human Disease Network
>> Targets derived from weak experimental activities
